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Articular cartilage is an avascular tissue that requires therapeutic intervention
methods. This work answers the following: determine transducer operation to optimize
the bioeffects; calculate the magnitude of pressure exerted on chondrocytes at an injury
site; and confirm the theoretical findings by an animal model.
Earlier work has shown that cellular response to US is maximized at the resonance
frequency of the cells. Resonance frequencies were calculated for chondrocytes in
various layers. The latter configuration closest resembles in vivo conditions and the
resonance occurred at 3.8±0.3 𝑀𝐻𝑧. The 3D model of US propagation in a rabbit knee
was constructed from MRIs to produce anatomically correct domains. US attenuates in
cartilage and 3D results showed that pressure is maximized at an injury site when the
transducer is placed in line with the site. Transducer positions that causes US waves to
traverse cartilage before reaching the injury site must be avoided. The 3D model is timeconsuming, and impractical for routine clinical usage. The average pressure delivered is
lower in pulsed low-intensity US compared to cLIUS.
A 1D model, which captured all the key results of the 3D model, was used to
calculate the temperature rise due to US dissipation – the cLIUS protocol produces

negligible increases in temperature. US attenuation can be overcome if the injury site lies
in the near-field of the transducer, where constructive interference tends to not only
cancel attenuation but delivers pressures higher than the transducer value – confirmed by
both 3D and 1D models.
Rabbit studies confirmed that cLIUS treatment significantly improved healing of
damaged cartilages, and defect sites filled, in contrast to fibrous filling in untreated
defects. Finally, a model that involves three intracellular pathways was used to
investigate mechanochemical response of a mesenchymal stem cell (MSC). Results
showed that MSCs could be prompted towards the condensation step by mechanical
stimulation at the resonance frequencies without any exogeneous chemical prompting,
and the key proteins formed much earlier than in in vitro experiments.
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CHAPTER 1 – INTRODUCTION
1.1 ARTICULAR CARTILAGE
Articular cartilage is an avascular tissue that lies between joints to protect bones from
bone on bone contact. The lack of blood vessels in cartilage translates to lack of nutrient
delivery and thus makes the healing of damaged areas very slow without outside
intervention (Oldershaw, 2012). The primary reason is that the cartilage lacks any
vascularization. Many intervention methods have been developed in recent years such as
chondrocyte implantation, bone marrow stimulation, tissue grafting, and mosaicplasty, to
name a few (Bhosale, Richardson, 2008). These methods are promising, though full
restoration has been elusive (Oldershaw, 2012). The research presented here provides
deeper insights in the use of ultrasound (US) as a method to treat cartilage injuries.
Specifically, it shows the effects that continuous low-intensity ultrasound (cLIUS) have
on cartilage tissue, beginning with a macroscopic model of a rabbit knee in 3D, and then
progressing all the way to the effects of the US within the cell envelope. US is primarily a
mechanical effect where at the interface between the cell and its environment, the
mechanical signals are translated into chemical signals which initiate a series of reactions
in certain cellular pathways.
1.1.1 OVERVIEW
Cartilage tissue is comprised of four different zones: the superficial zone, the middle
zone, the deep zone, and the calcified zone (Fox et al., 2009). The superficial zone is the
outermost layer and makes up 10-20% of total depth, while the middle zone makes up 4060%, and the deep zone 30-40%. The calcified zone is made up of very few hypertrophic
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chondrocytes. Each zone has different mechanical properties and the chondrocytes within
the zones vary in morphology, caused by the orientation of collagen fibers.
Chondrocytes are the building blocks for this tissue though they are the minority
component in cartilage tissue making up approximately only 1.65% in each square
millimeter of tissue (Hunziker et al., 2002). Their function is to maintain the matrix
infrastructure by synthesizing collagens and proteoglycans. Extracellular and pericellular
matrices (ECM and PCM) hold chondrocytes in place, and water fills in the gaps. The
surrounding matrices consist of collagens and proteoglycans providing structure. The
mechanical properties of the ECM and PCM tissue have been studied intensively as they
receive signals from outside environments to translate to cells.
1.1.2 OSTEOARTHRITIS
Osteoarthritis (OA) is a degenerative disease impacting the joint structure (Setton et
al., 1999). The progression of this disease drives hypertrophic chondrocytes to apoptosis.
The increase in population translates to an increase in the effect joint damage has.
Trauma and age cause defects and degradation of cartilage by increased production in
enzymes. This disease disrupts the ECM and PCM surrounding chondrocytes and
increases tissue permeability causing a decrease in elasticity and thus a subsequent
decrease in its load bearing capacity (Han et al., 2019).
Decreases in muscle mass and increases in fat mass occur with age (Ohkawa et al.,
2005). An important secretor of inflammatory markers lies in the fat pad that protects the
joint (Ioan-Facsinay, Kloppenburg, 2013). This positively correlates with the impact
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obesity has on progressing OA. Weight loss studies have shown a decrease in
compressive force seen at the knee as well as decreased cytokines (Vincent et al., 2012).
During the aging process our joints lose the lubrication of synovial fluid. This causes
the joint environment to evolve to an inflamed state by increased production of
inflammatory mediators (Jebens, Monk-Jones, 1959). Physical results from this disease
result in decreased physical function and joint pain. Knockout of an important cytokine
interleukin (IL)-6 has been studied, where OA worsened as a result (Greene, Loeser,
2015). Though this was not an expected result, it only highlights the necessity to continue
the study of the intricacies of this disease, as there are many inflammatory markers that
work cooperatively (Morrisette-Thomas et al., 2014).
Normal everyday movement is imperative for cartilage health as it assists in cartilage
homeostasis (Houard et al., 2013). Mechanical loads induce synovial fluid movement
into cartilage providing nutrients to chondrocytes. In the occurrence of injury elevated
levels of inflammatory markers are present causing swelling of the joint (Lieberthal et al.,
2015). The response to damage releases pro- and anti-inflammatory mediators where it is
thought that there exists a lack of control in the pro-inflammation marker response that
causes further damage leading to OA (Goldring 2000). Resolution of inflammation is
seen through anti-inflammatory markers produced early in post-injury.
1.1.3 IMPACT OF CARTILAGE INJURY AND LOSS
OA is not limited to the elderly and obese; healthy people that experience joint
injuries can also develop the disease. Cartilage is eroded through trauma and age,
degrading the tissue and damaging the bone surface as a result. Since chondrocytes are
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the minority constituent in cartilage tissue, their motility is limited. When joint tissues are
injured in a healthy person, a subsequent loss of cartilage is observed (Elsaid et al.,
2005). A study on anterior cruciate ligament (ACL) injuries (common in athletes) shows
a six-fold loss of cartilage and damage years after the injury occurred (Murrell et al.,
2001). In mechanical injury proteins are released that signal cell disruption and apoptosis
(Stevens et al., 2009).
1.1.4 CARTILAGE REPAIR AND REGENERATION
The oldest method of cartilage repair utilizes bone marrow stimulation (Steinwachs et
al., 2008). Methods were devised for marrow stimulation, which are located underneath
the cartilage, and which can be accessed via penetrating the subchondral bone. One
method that has been replacing older techniques like Pridie drilling or abrasion is
microfracture. In this technique the damaged layer of cartilage is debrided, and small
channels are drilled through the bone to reach marrow, providing a source of potent
MSCs and nutrients in an otherwise avascular area (Kuo et al., 2006). Though this
method has been continually improved, the technique often fails to repair the defect site
(Solheim et al., 2020).
Autologous chondrocyte implantation (ACI) was introduced in 1987 as a biological
cell-based approach to treat full-thickness cartilage defects (Grande et al., 1989). This
method uses chondrocytes isolated from biopsy samples and implanted in the defect site
under a periosteal cover. This environment provides protection and even nutrients to the
implanted chondrocytes. A study comparing various orientations of ACI showed the
efficacy of this method for cartilage repair (Horas et al., 2003). Furthermore, this method
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of cartilage repair has shown effective for long-term results even 10 to 20 years after
treatment (Peterson et al., 2010).
Tissue grafting is another area of cartilage repair. One such extensively studied
technique is osteochondral transplantation – or mosaicplasty (Robert, 2011). This method
uses osteochondral autographs harvested from areas of the knee where there is low
weight bearing. While utilizing donor tissues is promising, there exists differing
thicknesses in cartilage tissue. This method is also a difficult method of repair and
restricted for younger patients with small (less than 3cm in diameter) cartilage defects.
While these methods show success in cartilage tissue repair, they are also highly
invasive causing more inflammation. A small portion of these methods also show littleto-no difference in cartilage tissue repair. Some methods alone are not effective enough
and require combining techniques. These methods are also used when intervention
becomes a requirement for the health and well-being of a patient. While preventative
methods such as diet and exercise are important, US could be introduced at an earlier
stage to assist in the prevention of OA development.
1.2 ULTRASOUND IN THERAPEUTICS
The use of US in therapeutics has been utilized for bone healing for decades
(Hadjiargyrou et al., 1998). Ultrasound therapy has also proven useful for soft tissue
healing, pain relief, and a facilitator of healing (Best et al., 2016). Promising results
utilizing US as a therapeutic technique has probed the question of what else it could be
used for. Recent methods employing US as therapy include wound healing (Dyson et al.,
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2003), burn care (Waldrop, Serfass, 2008), and surgical techniques for tumor treatments
(ter Haar et al., 1989).
Treatment of cartilage with US was a natural shift as osteocytes (bone cells) and
chondrocytes are so closely related. Following this progression, the therapies detailing a
1.5MHz frequency have been thoroughly studied, and in some cases applied in
orthopedic clinical trials (Zhang et al., 2017). The efficacy of that regimen has been
debated, and in a limited clinical study was found to be ineffective at cartilage
regeneration as the sole therapeutic intervention (Loyola-Sanchez et al., 2012). This
could be due to the transducer positioning, voltage used, frequency of the transducer,
pulse duration, and many more variables.
1.2.1 IN VITRO ULTRASOUND APPLICATION
Ultrasound has been shown to assist in regenerating cartilage tissues with mechanical
stimulation (Cook et al., 2001). The economical option of utilizing this therapeutic and
noninvasive technique is attractive when compared to alternative methods. To begin to
study US effects on cells, in vitro models are used. Mechanical stimuli enhance
chondrocyte metabolic activity in alginate cultures (Min et al., 2007). In vitro ultrasound
application to chondrocytes has been done with various frequencies ranging from
0.8MHz to 5MHz, but primarily at 1.5MHz (Cui et al., 2006; Aliabouzar et al., 2016;
Budhiraja et al., 2017; Korstjens et al., 2008). All these in vitro studies show enhanced
ECM synthesis and chondrocyte proliferation, though a review determined that there
exists a lack of evidence for recommending this practice in clinical environments
(Rothenberg et al., 2017).
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1.2.2 EFFECT OF ULTRASOUND ON MSCS
The objective of applying ultrasound to marrow derived mesenchymal stem cells is to
induce chondrogenesis. The mechanism of this is not well understood but the goal here is
to help describe the phenomenon through mathematical modeling. The most crucial
factor in healthy cartilage tissue is TGF-. Though the requirement of TGF- has wide
agreement in literature there is also confirmation that it can induce degrading enzymes
when in high quantities by activating the ALK1 receptor (Van den Berg, 2011),
activating Smads1 and 5, which induces MMP13 synthesis.
Monitoring the effects of potential therapies through mathematical modeling has the
advantage of predicting whether the proposed method will work. Many pathways are
proposed to affect the health of a chondrocyte and therefore the surrounding
environment. Utilizing US as a stimulant for chondrogenesis has been widely reported to
positively impact chondrogenesis through activating mitogen activated kinase proteins
(MAPKs) (Takeuchi et al., 2008; Whitney et al., 2012).
This research is a continuation to model the behavior of cells under cLIUS. A
previous study on MSCs showed upregulation of cell proliferation regulators in vitro
without impacting multipotency (Budhiraja et al., 2017). Further experimentation with
cytokines showed suppression of inflammation, resulting in a chondroprotective role of
cLIUS (Sahu et al., 2019). Additionally, the gene expression of master chondrogenic
marker SOX9 was upregulated using cLIUS (Sahu et al., 2020). The phosphorylation of
ERK was determined to be key in these results, which is a key intracellular signaling
molecule in cell-surface receptor pathways.
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1.2.3 IN VIVO ULTRASOUND APPLICATION
Preliminary studies focus on in vitro US applications and modeling and laboratory
experiments are done in highly controlled environments. Simply transferring the
therapeutic regimen to the in vivo environment will not produce the expected results as
the complexity of the system has increased. This leads to the use of animal models for US
therapy to further study its effects in vivo. Rabbit studies done by Yang et al., using
1.5MHz pLIUS showed no significant potential using the standard regimen for bone
healing (Yang et al., 2014).
While these results showed no advantage for utilizing pLIUS for cartilage
regeneration, there exists other in vivo experiments that show positive histological
staining indicating upregulation in ECM component expression. Sheep studies done with
bilateral cartilage defects show the formation of cartilage tissue treated with pLIUS at
200mW/cm2 (Vahedi et al., 2021). Additionally, a pig study using 1.5MHz pLIUS
showed an attenuation of the progression of cartilage degeneration in the joint (Naito et
al., 2010). These animal studies conclude that US has potential for therapeutic
intervention methods to treat OA.
1.3 OBJECTIVES
Previous theoretical and experimental outcomes have shown the benefits of cLIUS.
Continuation of this research is necessary to examine the promotion of bioeffects.
The objectives of this dissertation are as follows:
•

To evaluate US propagation in the joint on a macroscopic scale to examine the
system pressure and ensure optimal transducer placement for maximal effects.
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•

Develop a mathematical model to describe the damping of US signal of the PCM
surrounding the chondrocyte.

•

Mathematically evaluate enhanced bioeffects US modulates during the first stage
of chondrogenesis through integrated pathway kinetics.

The overall goal here is to examine pressure responses from large to micro scale to
better understand the systemic response after microfracture procedures and cLIUS
treatment. Analyzing this will allow for better understanding the role of cLIUS for in vivo
therapeutics for cartilage repair in order for clinical application. A major contribution
from this thesis is to offer a more complete picture of the connectivity between the
mechanical stimulation and the secretion of new cartilage from stimulated cells, and
providing a more quantitative picture of how the mechanical/chemical mechanisms
function. Another contribution of this thesis is that it places the ultra-sound treatment of
cLIUS on a firmer footing and advances its utility as a therapeutic method for cartilage
regeneration.
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CHAPTER 2 – COMPLETE SYSTEM MODEL
2.1 INTRODUCTION
This chapter will focus on the modeling of ultra-sound propagation in the rabbit knees
with the commercial software package COMSOL Multiphysics (COMSOL Inc.,
Burlington, MA, USA). Although there have been significant advancements in software
to solve complex physical problems, the actual modeling of US propagation in a knee
remains a challenging task. Two problems stand out as particularly challenging in nature.
First, the domain, which is the space in which the US model is solved, is very complex
and it varies from animal to animal, person to person. Second, the materials that
constitute the domain are not isotropic, homogeneous (as in the case of in vitro studies),
but are best described as multi-phase materials with anisotropic properties, which require
more sophisticated models such as Biot theory to describe the US propagation.
Previous modeling on the chondrogenic environment has been utilized to show the
potential of US in the joint environment in 2D (Miller 2017). These 2D models were
generated from sagittal views of rabbit and sheep MRIs. Theoretical results show that the
placement of the transducer is key in optimal intensity reached at the defect site, as seen
by the shift up/down on the sagittal view. Though these results give an insight to the
environmental response, the bone geometry changes considerably when moving the
transducer in the axial view.
2.2 MATHEMATICAL MODELING
While many studies and models have been developed for ultrasound applications in
vitro (Rothenberg et al., 2017), there is a lack of in vivo studies. The translation of results
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from in vitro studies to in vivo applications is complicated because the in vitro studies
lack the necessary complexity. In the past, some naïve conclusions about in vivo usage
have been made, on the basis of in vitro findings. But extrapolating findings to another
milieu that differs so much from the in vitro environment has oftentimes led to
disappointing outcomes. Unfortunately, the stark reduction in complexity, found in in
vitro experiments, specifically the lack of recreating the chondrogenic environment, has
placed a questionable value on its use in clinical applications (Duda et al., 2004). Another
aspect that frustrates researchers, is the inability to perform non-obtrusive monitoring of
the chondrogenic environment on a continuous basis. Thence, we need to resort to
mathematical modeling to provide these insights. Here, a complete model of the overall
system is presented, starting with the piezo-electric transducer that delivers the pressure
and progressing to the propagation of the pressure in an anatomically correct threedimensional model. However, one should ask what is really gained from modeling the
propagation in a knee?
The COMSOL modeling has been used to answer two key questions. First, we want
to identify the optimal frequency bandwidth where US-induced bioeffects are maximized
within the in vivo environment (Louw et al., 2013). Secondly, we want to determine
what is the pressure at an injury site – the magnitude of the pressure on chondrocytes at
the injured site will determine the amount of mechanical/chemical interaction that occurs
on the cellular level and ultimately determine the extent to which the cells will respond to
the mechanical stimulation. Clearly, to answer the second question we must solve the
macroscopic model of US propagation through the knee. The 3D modeling of US
propagation in a knee is an involved process. A methodical description of the

12

macroscopic model should start with the piezoelectric transducer that provides the input
for the pressure field.
2.3 KLM EQUIVALENT CIRCUIT FOR THE PIEZOELECTRIC TRANSDUCER
The Krimholtz, Leedom, & Matthaei (KLM) equivalent circuit has been used to
describe the transition from electric input impedance to an acoustic impedance in
ultrasonic transducers (Krimholtz et al., 1970; Castillo et al., 2003; Kim et al., 2019; Kar,
Wallrabe, 2020). Other one-dimensional methods are available to describe equivalent
circuits such as the Mason model (Kar, Wallrabe, 2020) though negative capacitance
values prove problematic (Sherrit et al., 1999). Utilizing the KLM mathematic model
allows for a pressure prediction at the surface of the transducer when coupled with
transmission line theory and transfer functions (Castillo et al., 2003; Kulkarni, 2011).
This method of calculating pressures at the transducer surface has been well
established in literature (Rathod 2019). Previous modeling utilized the KLM model of an
immersion transducer coupled to the ultrasonic field using the transfer matrix/angular
spectrum approach (Louw et al., 2015). The model here describes the maximum pressure
propagated at the center of the transducer in a more simplistic fashion. Figure 1 shows the
circuitry design with the piezoelectric element and matching layers (Krimholtz et al.,
1970).
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Figure 1: KLM Equivalent Circuit. Thickness of each layer is d, and impedances Z with
subscripts are impedances radiating into the surrounding. Capacitor C0, impedance X1, and
transformer turn ratio ϕ are calculated in Appendix B.

Most ultrasound transducer manufacturers keep the internal components as
proprietary information; therefore, third party users need to resort to a model to predict
the output pressure given an input frequency and voltage. The transducer modeled here is
an unfocused 3.5MHz Olympus immersion transducer with a 6mm diameter (V384-SU)
at a manufacture calibrated frequency of 3.8MHz. Previous experiments have been done
using a transducer of different frequency and size from the same manufacturer (Olympus
NDT, MA), allowing for output pressure calibration to be done (Louw et al., 2015). This
was done by adding a small matching layer with properties similar to air in front of the
wear plate matching layer. The thickness of the layer, along with its impedance was
varied to sufficiently calibrate the model.
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The goal of using this model is to develop a relationship between the input voltage
𝑉𝑖𝑛 , and the output impedance 𝑍𝑜𝑢𝑡 , which can be used to calculate initial pressure values
at the front of the transducer face (Bigelow, 2001). The initial pressure values can then be
coupled with a sinusoidal signal generator to produce a frequency and time dependent
pressure. Modeling the transducer begins with electric impedance shown by equation
2.3.1:

𝑍𝑒 =

1
𝑍𝑎
+ 𝑖𝑋1 + 2
𝑖𝜔𝐶0
𝜙

2.3.1

where 𝜔 is the angular frequency, 𝐶0 is the capacitor, 𝑋1 the impedance, 𝜙 the
transformer turns ratio, and the input impedance of the transmission line is

𝑍𝑎 =

𝑍1𝑖𝑛 𝑍2𝑖𝑛
𝑍1𝑖𝑛 + 𝑍2𝑖𝑛

2.3.2

Circuit parameters are well described in literature, and full calculations for each can
be seen in Appendix B. The impedances 𝑍1𝑖𝑛 and 𝑍2𝑖𝑛 are calculated based on the
backing material and matching layer material 𝑍1,2 as well as the piezoelectric element
impedance 𝑍0 ,

𝑍1,2𝑖𝑛 = 𝑍0

𝜔𝑑
𝑍1,2 + 𝑖𝑍0 tan ( 2𝑐 )
𝜔𝑑
𝑍0 + 𝑖𝑍1,2 tan ( 2𝑐 )

2.3.3

The impedances of the matching layers are similarly calculated, using the characteristic
impedance of the layer itself. Together with transmission line theory this allows for the
solution of the voltage-driven displacement response equations 2.3.4 and 2.3.5:
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𝜈1 =

𝑒𝑥𝑝(𝑖𝑘𝑑/2) − 𝛤2 exp (−𝑖𝑘𝑑/2)
(1 + 𝛤1 )
𝜙𝑍𝑒 (exp(𝑖𝑘𝑑) − 𝛤1 𝛤2 exp (−𝑖𝑘𝑑))

𝜈2 =

𝛤1 𝑒𝑥𝑝(−𝑖𝑘𝑑/2) − exp (𝑖𝑘𝑑/2)
(1 + 𝛤2 )
𝜙𝑍𝑒 (exp(𝑖𝑘𝑑) − 𝛤1 𝛤2 exp (−𝑖𝑘𝑑))

2.3.4

2.3.5

where 𝑘 is the wavenumber, and current transmission coefficients are:

𝛤1,2 =

𝑍0 − 𝑍1,2
𝑍0 + 𝑍1,2

2.3.6

Each matching layer velocity can be determined using the forward velocity from the
previous layer shown by equation 2.3.7:

𝜈𝑥 =

𝑍𝑥 (𝜈𝑥−1 )
𝑍𝑥 cos(𝑘𝑥 𝑑𝑥 ) + 𝑖𝑍𝑜𝑢𝑡 sin(𝑘𝑥 𝑑𝑥 )

2.3.7

where x denotes the layer number. Finally, pressure radiated from the face of the
transducer can be solved for as a function of the last layer velocity and transducer face
area.
𝑃 = 𝑍𝑜𝑢𝑡 𝜈𝑜𝑢𝑡 /𝐴𝑟𝑒𝑎

2.3.8

where 𝜈𝑜𝑢𝑡 is the last layer velocity. These equations provide an output pressure which
shows a linear relationship to input voltage, as shown in Figure 2 with an input voltage of
3.5Vpp and 3.8MHz frequency. Material properties used are listed in Table 1.
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Figure 2: Output transducer pressure dependent upon input rms voltage for 3.5MHz transducer.

Piezoelectric Element
𝑐𝑃𝑍𝑇

4897 𝑚⁄𝑠

𝜌𝑃𝑍𝑇

5840 𝑘𝑔⁄𝑚3

𝑑

𝜆⁄2 𝑚𝑚

𝑍𝑃𝑍𝑇

20.17 𝑀𝑅𝑎𝑦𝑙

ℎ33

2.19𝑒9(1 + 0.029𝑖)𝑉/𝑚 (Sherrit et al., 2007)

𝜀

1.36𝑒 − 8 𝐹/𝑚

𝑐𝑤

1480 𝑚⁄𝑠

𝑑𝑤

𝜆⁄4 𝑚

𝑍𝑤

√𝑍𝑤𝑎𝑡𝑒𝑟 ∗ 𝑍𝑃𝑍𝑇 (Kulkarni, 2011)

Wear Plate

Table 1: Material property values for the KLM model.
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The voltage applied to the transducer is output from a function generator that requires
peak-to-peak voltage input. By varying the input voltage, the linear relationship between
voltage and pressure is used to predict the pressure output at the face of the transducer.
For the purposes of the 1.5MHz transducer study, the same KLM model was applied with
the same constraints as the 3.5MHz transducer. A similar linear relationship was
obtained, as shown in Figure 3.

Figure 3: Output transducer pressure dependent upon input rms voltage for 1.5MHz transducer.

As we can see from comparing Figure 3 with Figure 2, the voltage input required is
much higher to produce the same pressure output as the 3.8MHz transducer. In our
experimental ultrasound procedure, the applied voltage was 3.5Vpp (peak-to-peak). The
pressure output, based on the KLM model with this input, is shown to be 3kPa. To keep
consistency, we used 3kPa for all the modeling, regardless of the transducer choice. To
obtain this pressure for the 1.5MHz transducer an approximate voltage input of 9Vpp is
required. The pressure output (at the transducer surface) of 3kPa is used for all further
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modeling in a 3D environment. The KLM model is used to calculate the pressure at the
transducer surface and this value is an input for the COMSOL model.
As will be discussed later, the 3D simulations are computationally very expensive,
and are not currently an option for routine clinical applications. In an effort to bring some
computational guidance to the clinical setting, we also propose the use of a simple onedimensional model to predict defect site pressure and temperature changes. A drastic
increase in temperature can result in cell death, therefore analyzing this with cLIUS
application is vital.
2.4 COMSOL MODELING
2.4.1 PRESSURE ACOUSTICS MATHEMATICS
The pressure acoustics module in COMSOL is governed by the wave equation with
assumptions of adiabatic flow and lossless, i.e. no viscous effects, together with a linear
equation of state. Applying a harmonic solution in the general form of 𝑝(𝑥, 𝑡) = 𝑝(𝑥) ∗
𝑒 𝑖𝜔𝑡 where 𝑝(𝑥) is the instantaneous pressure and 𝜔 is the angular frequency results in
the inhomogeneous Helmholtz equation in the frequency space (Morse, Ingard, 1986):

∇ ∙ [−

2
𝑘𝑒𝑞
𝑝𝑡
1
(∇𝑝𝑡 − 𝒒𝑑 )] −
= 𝑄𝑚
𝜌𝑐
𝜌𝑐

2.4.1

Pressure here is 𝑝𝑡 the total pressure, 𝒒𝑑 and 𝑄𝑚 are sources, and 𝑘𝑒𝑞 is a function of
the angular frequency 𝜔 and speed of sound 𝑐𝑐 so that 𝑘𝑒𝑞 = (𝜔⁄𝑐𝑐 )2 (Zwikker, Kosten,
1949). The total acoustic pressure 𝑝𝑡 is the sum of the pressure solved for, including the
scattered pressure and the background pressure. When damping occurs in the system,

19

both density 𝜌𝑐 and 𝑐𝑐 are complex values which is represented by the subscript notation.
In the case of user defined attenuation, we set 𝜌𝑐 = 𝜌𝑐 2 ⁄𝑐𝑐2 and 𝑐𝑐 = 𝜔⁄𝑘. Material
properties of the model prescribe the density 𝜌 and speed of sound 𝑐 in each domain. The
wave number in this case is defined as (COMSOL, 2018):
𝑘=

𝜔
𝛼
− (𝑙𝑛(10) ) 𝑖
𝑐
20

2.4.2

where 𝛼 is the attenuation coefficient. Source terms do not apply here and are set to zero
𝒒𝑑 = 𝑄𝑚 = 0. When modeling in the frequency domain, the specification of a pressure
source at the position of the transducer serves to mimic the action of the transducer
surface, thus a cylindrical radiation boundary condition is specified where 𝑝0 is the
amplitude of the harmonic pressure source. The radiation boundary condition is applied
to the outermost boundaries of the model to depict minimal reflection of the wave to
domains which lie adjacent to the modeling domain. This boundary condition, using a
plane wave for the transducer, is set to (COMSOL, 2018):

−𝐧 ∙ (−

1
𝑖𝑘𝑝𝑡
𝑝0
∇𝑝𝑡 ) +
= (𝑖𝑘 − 𝑖(𝐤 ∙ 𝐧)) 𝑒 −𝑖(𝐤∙𝐫)
𝜌𝑐
𝜌𝑐
𝜌𝑐

2.4.3

where 𝑘 is the wavenumber, 𝐤 is the wave vector set to 𝐤 = 𝑘𝐧𝐤 with 𝐧𝐤 being the unit
vector in the direction of propagation.
2.4.2 POROELASTIC WAVES MATHEMATICS
Mathematical modeling was done using COMSOL Multiphysics in an effort to
optimize the cLIUS application (cLIUS or continuous low-intensity ultra-sound). When
cells are subjected to US, the cells act like oscillators, in a mechanical sense, and
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therefore resonance frequencies exist where the cells couple most effectively with the
impending US field (Kim et al., 2008; Miller et al., 2017). This results in complex
biomechanical behaviors effecting metabolic activity of a cell. This coupling can be
understood as the transfer of mechanical energy to the cells. In a linear model, the
amount of mechanical energy (kinetic + potential) approaches infinity, but nonlinear
effects will limit the total mechanical energy (Miller et al., 2017). Louw et al. reported
the first linear resonance modeling of cells suspended in solution and found that
chondrocytes have a primary resonance frequency of 5 MHz (Louw et al., 2013). That
model was expanded by Miller et al., to include nonlinear effects. The nonlinearities
stemmed from the use of an equation of state as proposed by Shchetinin (Shchetinin,
1991). The nonlinear analysis showed that the resonant frequencies lie in a range of 3.54.1MHz (Miller et al., 2017). Translation to the in vivo model can be assumed a similar
range as the model of a chondron in an ECM plug in suspension are closest to the in vivo
environment. The mathematical model that was used for the linear resonance studies
were Biot’s poroelastic acoustics solving the wave equation for pressure, sound pressure
level, and stored energy density in the frequency space. Expansion of work done on
Miller et al., 2017 has been done here by confirming the chondrocyte environment and
expansion to the MSC. Biot theory is commonly used in calculating pressure in biological
materials and more specifically in cartilage tissue (Suh, DiSilvestro, 1999). A brief
review of Biot’s theory is presented. The governing equation for a poroelastic model is
given by (COMSOL, 2018):
−∇ ∙ 𝝈 = 𝑭

2.4.4
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where the divergence of the Cauchy stress tensor 𝝈 is set equal to the source term 𝑭, and
this source term is defined as a body load. The strain tensor is defined as (Atalla et al.,
1998)
1
𝝐 = [(∇𝒖)𝑇 + ∇𝒖]
2

2.4.5

and is dependent on displacement of the porous material 𝒖. The expressions for
poroelastic waves derived by Biot with the assumption of time-harmonic dependence for
both displacements 𝒖 and 𝒘 are (Biot, 1956; Allard, 1993)
−𝜌𝑎𝑣 𝜔2 𝒖 + 𝜌𝑓 𝜔2 𝒘 − ∇ ∙ 𝜎 = 0

2.4.6

−𝜌𝑓 𝜔2 𝒖 − 𝜌𝑐 𝜔2 𝒘 + ∇𝑝𝑓 = 0

2.4.7

where 𝑝𝑓 is the pore pressure. This is the pressure which the COMSOL solves for instead
of the fluid displacement 𝒘. This simplifies equation 2.4.7 to

𝑤=

1
(∇𝑝𝑓 − 𝜌𝑓 𝜔2 𝒖)
𝜌𝑐 𝜔 2

2.4.8

This can be then applied to equation 2.4.6 so that it becomes
−𝜌𝑎𝑣 𝜔2 𝒖 −

𝜌𝑓
(∇𝑝𝑓 − 𝜌𝑓 𝜔2 𝒖) − ∇ ∙ 𝜎 = 0
𝜌𝑐

2.4.9

The same assumption of time-harmonic can be applied to the elastic wave equation and
can be written as (Biot, 1956)

− (𝜌𝑎𝑣 −

𝜌𝑓2
) 𝜔2 𝒖 − ∇ ∙ (𝝈 − 𝒔0 ) = 𝑭
𝜌𝑐

2.4.10

where 𝝈 is the total stress tensor of the fluid and porous material, 𝜌𝑓 is the density of the
fluid, 𝜔 the angular frequency defined as a function of the frequency 𝜔 = 2𝜋𝑓, and 𝜌𝑎𝑣
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is the average density defined by the summation of the porous matrix density 𝜌𝑑 and the
fluid density (COMSOL, 2018):
𝜌𝑎𝑣 = 𝜌𝑑 + 𝜖𝑝 𝜌𝑓

2.4.11

The complex density 𝜌𝑐 is described by (COMSOL, 2018)

𝜌𝑐 =

𝜇̃𝑓
𝜏¥
𝜌𝑓 +
𝜖𝑝
𝑖𝜔𝜅

2.4.12

where 𝜇̃𝑓 is the frequency dependent viscosity, 𝜅 is permeability, 𝜏¥ the tortuosity factor,
and 𝜖𝑝 is the porosity. Working in the high frequency application of ultrasound requires a
correction as the flow profile can no longer be considered Poiseuille like. This impacts
the reference frequency as well as the viscosity. The frequency dependent viscosity is
defined as (COMSOL, 2018)
𝜇̃𝑓 = 𝜇𝑓 𝐹 (√𝑓⁄𝑓𝑟 )

2.4.13

where 𝜇𝑓 is the fluid dynamic viscosity, 𝑓 the working frequency, and 𝑓𝑟 the reference
frequency. The viscosity model used in these cases is Biot’s high frequency range, where
the reference frequency is characterized by the pore size which is calculated as follows
(Biot, 1956):
𝑓𝑟 =

𝜇𝑓
2𝜋𝑎2 𝜌𝑓

2.4.14

Here a is the pore size. The total stress tensor is a combination of contributions from the
drained porous matrix and the fluid so that (COMSOL, 2018)
𝝈 = 𝝈𝑑 − 𝛼𝐵 𝑝𝑓 𝑰

2.4.15
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Applying the identity tensor 𝑰 results in the pore pressure only contributing to the
diagonal of the total stress tensor. The fluid parameters used in modeling are those of
water since it has similar properties as the synovial fluid (Fox et al., 2009). The
parameter 𝐹 is a frequency dependent on the viscous drag and defined by Bessel
functions of the first kind (Biot, 1956).

−√−𝑖𝐽1 (√−𝑖𝑄)
−√−𝑖𝐽1 (√−𝑖𝑄)
1
𝐹 = [𝑄 (
)⁄(1 + 2𝑖 (
))]
4
𝐽0 (√−𝑖𝑄)
𝐽0 (√−𝑖𝑄)

2.4.16

Biot’s module 𝑀 is described by (Biot, 1962)
𝛼𝐵 − 𝜖𝑝
1
(1 − 𝛼𝐵 )
= 𝜖𝑝 𝜒𝑓 +
𝑀
𝐾𝑑

2.4.17

the drained bulk modulus 𝐾𝑑 is a function of the specified poroelastic parameters. In this
case it is the Young’s modulus 𝐸𝑑 and Poisson’s ratio 𝜈𝑑 . The various choices COMSOL
allows as an input can be interchanged due to the mathematical relationship between the
shear modulus, Poisson’s ratio, and Young’s modulus (Biot, 1941). Note that the BiotWillis coefficient 𝛼𝐵 is dependent solely upon the porous matrix properties while Biot’s
module depends on both the fluid and porous matrix properties. The body load is
dependent upon angular frequency and fluid pressure, which also acts as a spherical
contribution to the diagonal of the stress tensor resulting in (Biot, 1956):
𝜌𝑓
∇𝑝
𝜌𝑐 𝑓

2.4.18

𝒔0 = 𝛼𝐵 𝑝𝑓 𝑰.

2.4.19

𝑭=
And
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2.4.3 ACOUSTIC – POROUS BOUNDARY
Using the Multiphysics component of COMSOL, the pressure acoustics physics is
combined with the poroelastic waves physics. It is assumed that at the interface, there is
no loss between the two. Continuity of pressure on the boundary is (COMSOL, 2018):
(𝑝𝑡 )𝑎𝑐𝑜𝑢𝑠𝑡𝑖𝑐 = (𝑝𝑡 )𝑝𝑜𝑟𝑜𝑢𝑠

2.4.20

The pressure load from the acoustics physics is set equal to the pressure experienced by
the porous material through (COMSOL, 2018):
−𝐧(𝑝𝑡 )𝑎𝑐𝑜𝑢𝑠𝑡𝑖𝑐 = 𝐧

2.4.21

These mathematical models with their accompanying boundary conditions are used to
analyze the effects of an applied US field on cells in vitro.
2.4.4 MACROSCOPIC MODEL
Three-dimensional modeling of the system requires magnetic resonance images
(MRIs) to be collected. These were imported to Simpleware ScanIP (Synopsys®, CA), a
3D image processing and model generation software, where the different tissues were
segmented, and a finite element mesh analysis was done to smooth edges and corners and
produce a 3D model. The output 3D mesh was then imported to COMSOL Multiphysics
(COMSOL Multiphysics®, MA) where-after the acoustics physics package was applied.
The output pressure from the KLM model was used as the initial pressure with timeharmonic dependence, 𝑝(𝑡) = 𝑝0 sin(𝜔𝑡) as consistent with the function generator used
to supply power to the transducer. To reduce the computational demand, the model is
solved only on a section of the knee 12mm in height.
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2.4.5 SENSITIVITY ANALYSIS
Modeling of the system was done in COMSOL Multiphysics which gets
progressively more complex, beginning with in vitro modeling of a mesenchymal stem
cell (MSC) or chondrocyte – which was used to find the optimal frequency at which to
apply ultrasound – and evolving to a macroscopic model of a rabbit knee joint. An
important part of the modeling setup is the mesh size. This specifies how many points
within the model are solved for and defined as the maximum mesh element size. General
guidelines for this are prescribed by COMSOL as a function of material velocity
𝑐𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 and operating frequency.
𝑀𝑒𝑠ℎ 𝑠𝑖𝑧𝑒 = 𝑐𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 ⁄𝑓/𝑁

2.4.22

where the number of elements 𝑁 was calculated through the use of a mesh refinement
study so that a balance was struck between computational energy and sufficient data
collection. The higher the number of elements, the more memory is required to solve.
COMSOL prescribes this value to be anywhere from 1 to 5. These sensitivity analysis
results differed for the various geometries but generally 𝑁 was no more than three. In
cases where 𝑁 was not large enough the solutions did not converge. As the mesh size is
dependent on material properties as well as applied physics, it is important to obtain
accurate values. Parameters used in the pressure acoustics module are listed in Table 2.
Tissue

Sound velocity (𝑚/𝑠)

Density (𝑘𝑔/𝑚3 )

Reference

Marrow

1410

990

Kawasaki 2015, Hughes 2007

Bone

3844

1900

Weiss 2000, Cameron 1996

Cartilage

1658

1473

Myers 1995, Basser 1998
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Meniscus 1640

1470

Basser 1998

Fat

1470

950

Madsen 1978, Martin 1994

Muscle

1550

1073

Feigin 2020, Kuthe 2016

Skin

1645

1020

Moran 1995, Liang 2009

Blood

1575

1055

Azhari 2010

Table 2: Speed of sound and density values for tissues in the 3D modeling environment.

For acoustic pressure propagation through the system two options were available: the
pressure acoustics module and the poroelastic waves module. Both modules were used to
solve the wave equation with different boundary conditions, resulting in a system of
partial differential equations. Many studies have presented extensive derivations of the
wave equation, which has been briefly reviewed here (Green et al., 1976).
2.5 THEORETICAL MODELING
2.5.1 IN VIVO MODELING TO DETERMINE THE OPTIMAL FREQUENCY
Traditionally a frequency of 1.5MHz was used for most US treatments, regardless of
tissue type and injury (Lai et al., 2021). Louw et al (Louw, et al., 2013) provided
important information on the role of US frequency on the cellular response. In an
experimental study chondrocytes were suspended in an aqueous medium and the
bioreactor was exposed to US at different frequencies. A significant increase in the
expression of c-Fos was observed at 5±0.5 MHz, compared to frequencies at 2 and
8MHz. The in vitro study was complemented by a mathematical model of the response of
a suspended chondrocyte to an US field. It turned out that 5MHz corresponds to the first
resonance frequency of the cell. At 5±0.5 MHz, the impending US transfers mechanical
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energy to the cell, which causes an increase in ERK phosphorylation and the upregulation
of SOX9 expression (Sahu et al., 2020). Motivated by these results, we conducted a
computational study of chondrocytes in different surroundings to determine the first
resonance frequencies. Chondrocyte models were confirmed from Miller et al., and
expanded upon here with zonal variations and mesenchymal stem cell suspensions. The
different conditions were: (1) chondrocytes suspended in medium, (2) a chondron
(chondrocyte plus PCM – i.e. pericellular matrix) suspended in medium, (3) a chondron
embedded in ECM– i.e. extra-cellular matrix), and (4) chondrons in ECM where the
ECM is layered into a superficial zone, middle zone and deep zone. Suspended cell
computational studies were also done on the MSC and the MSC in a blood clot.
As described previously by Miller et al., to keep the computational requirements to a
minimum the geometry was scaled by minimizing the culturing environment by a height
of 3/4 and a width of /2 (Miller et al., 2017). The geometry for a chondrocyte and
MSC (mesenchymal stem cell) were modeled as two concentric spheres of different
diameters to represent the cytoplasm and nuclear compartments of a cell. The geometries
where a cell was embedded in an ECM or blood clot were done as a cylindrical plug
equivalent to Guilak and Mow with a height of 65m and radius of 32.5m (Guilak,
Mow, 2000). The pericellular matrix thickness in the chondron (the chondrocyte, with a
PCM layer around it, is termed a chondron) and chondron + ECM model was designated
to be 2.5m as in previous modeling since the sensitivity lies in the value of Young’s
modulus (Miller et al., 2017). The final in vitro model was of a partial cartilage biopsy
punch differentiating the three zones of cartilage with an overall thickness of 0.3mm (Fox
et al., 2009) containing a chondron in each layer. Since chondrocytes make up less than

28

2% of cartilage tissue (Hunziker et al., 2002), only one was embedded in each zone,
though the spherical shape was maintained. In each model the cell is positioned at an
antinode for each frequency; where the ultrasound source is positioned at the bottom of
each cylinder. A complete set of tissue properties can be seen in Appendix C. The
different in vitro modeling geometry setups can be seen in Figure 4.

f
a

c

b

d

e

Figure 4: COMSOL in vitro cell geometries. a) a suspended MSC in water. b) a MSC embedded
in a blood clot in water. c) a chondrocyte suspended in water. d) a chondron (chondrocyte with
PCM layer) suspended in water. e) a chondron embedded in ECM in water. f) zonal
differentiation of the ECM with chondrons embedded in each layer in water. The overall
thickness of cartilage is broken up into zones as follows: superficial zone (SZ) 15%, middle zone
(MZ) 50%, and deep zone (DZ) 35%.

Previous work done by Louw et al. (Louw et al., 2015) showed that a 5MHz
transducer driven at a peak-to-peak voltage of 6V, produced a pressure of 14kPa. That
pressure was used in in vitro modeling as the pressure amplitude in a boundary condition.
Applying a parametric sweep by varying the frequency of the applied US field, the
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system attains a peak energy density at a specific frequency, which corresponds to the
resonance value found here. The resulting storage energy density can be seen in Figure 5.
Here, the frequency at which storage energy density peaks is referred to as the resonant
frequency. Adding layers to the chondrocyte (+PCM, +PCM+ECM) or the MSC (+blood
clot) shifts its resonance frequency. In Figure 5, the chondrocyte in suspension has a
resonance frequency around 5MHz, confirmation of modeling done by Louw et al.
(Louw et al., 2013). When the PCM layer is added, the resonance frequency of the
chondron drops to 4.3MHz. This result is in agreement with Miller et al. where the
maximum energy density lies in the range of 3.7 to 4.1 MHz for the chondron. When the
chondron is placed in ECM, the resonance frequency is 3.8MHz, which is confirmation
of modeling done by Miller et al. (Miller et al., 2017). The MSC in suspension has a
resonance frequency of 2.3MHz, and in the presence of a blood clot it drops to 2.1MHz
(Keep in mind the properties of an MSC and chondrocyte differ). The peaks at 6.4MHz
are secondary resonance values. It is important to examine the effects of US on the MSC
and its environment, as injuries and intentional creation of defects leads to a flood of
blood from the bone which is rich in MSCs and nutrients. MSCs are stem cells which can
differentiate into chondrocytes. As demonstrated in in vitro experiments by (Sahu et al.,
2020), MSCs can differentiate into chondrocytes if they are exposed to a daily regimen of
US. This is an important result, because in vitro chondrogenesis was always done by
adding TGF-𝛽 to the culture medium. (In other words, the MSCs, which usually require
chemical prompting by TGF-𝛽 to differentiate into chondrocytes, now differentiate only
by mechanical prompting with US). Utilizing US as a stimulant can result in inducing
chondrogenesis, which is examined further in Chapter Four. The response elicited by the
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cell is maximal at the peaks from Figure 5, though with changes in parameters there
could be peak shifting. The results of Sahu et al. add another dimension to future clinical
treatments (Sahu et al., 2019); treat patients immediately after injury with US that
matches the resonance frequency of MSCs – this will expedite the formation of new
chondrocytes. Then the treatment shifts to US treatments at the resonance frequency of
chondrocytes to expedite cartilage secretion.
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Figure 5: Resonant frequency plot for cell in vitro COMSOL simulations.
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The three zones of articular cartilage are analyzed in the biopsy punch in vitro model
in two separate scenarios where each have the same mechanical properties (SZP), and
when the zones have their own specific properties (DZP) (Guilak et al., 2005). Again,
applying a parameter sweep with varying frequencies the results show a shift in resonant
frequency to 3.6MHz, within the range found by Miller et al. (Miller et al., 2017). Figure
6 below shows the resonant frequency and pressure results. It is important to note that
even with different zonal properties the peak pressure still lies at 3.6MHz. This further
illustrates that utilizing the optimal frequency results in efficient energy coupling. The
broad spectrum of resonant frequencies with the DZP is promising for macroscopic
models as the addition of more tissues will shift the peaks.
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a

b

c

Figure 6: COMSOL biopsy punch results for a) SZP resonant frequencies, b) DZP resonant
frequency, and c) peak pressure for both SZP and DZP.

The modeling of the chondrocyte in different environments to determine the
resonance frequency was key in determining the transducer parameters for the
experimental work. Based on the results of the in vitro modeling and available
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transducers from Olympus, resulted in the selection of a 3.5MHz transducer with a 0.25”
diameter calibrated to 3.8MHz. The operating peak to peak voltage was set to 3.5Vpp.
The model that was used to calculate the pressure at the transducer surface, as a function
of applied voltage, is the KLM model. A KLM model calibrated by previous experiments
shows how the new 3.8MHz transducer pressure output changed to 3kPa due to the
decrease in transducer diameter by half, compared to the results of Louw et al. ( Louw et
al., 2015). The frequency of 3.8 MHz and pressure of 3 kPa were then used in a
macroscopic model of the rabbit knee.
2.5.2 COMPUTATIONAL STUDY OF US PROPAGATION IN A KNEE
To answer the second question (cf. section 2.2), a finite element method (COMSOL)
is used to solve for the governing equations in the solution domain. High resolution MRI
pictures (DICOM files) are imported into ScanIP (Simpleware). ScanIP is a robust 3D
image segmentation software that generates high-quality models through user
manipulation. In ScanIP the different subdomains are defined; these subdomains include
bone, muscle, synovial fluid etc. Each tissue has its own unique coloring which can be
segmented through a threshold application. For humans the software has an
autosegmenting function, which could not be used here due to the small dimensions of
the rabbit anatomy. Once a tissue has been identified and isolated, ScanIP creates a finite
element (FE) mesh which can be refined and smoothed without compromising the
topology of the geometry. The time it takes to generate a final model depends on how
complex the geometry is and how many iterations the user inputs. Figure 7(c) shows the
finite element model of the bone segment and Figure 7(d) is the FE model of the
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combined domain. An overview of this process can be seen in Figure 7. A high resolution
(9T) MRI scanner was used to obtain the DICOM file in Figure 7(a).
a

b

c

d

Figure 7: Workflow from ScanIP to COMSOL. a) raw slice from ScanIP. b) segmented bone
tissue in ScanIP. c) 3D FE mesh generation from ScanIP. d) ScanIP FE mesh import to COMSOL
with cartilage, muscle, and skin layers

A useful feature of ScanIP is that the final mesh can be exported directly into a
COMSOL file, which is imported to the COMSOL geometry branch where the finite
element model can be further manipulated. In this model the femur has been extruded and
Boolean operations have been used to add a 0.3mm layer which is designated as cartilage
tissue. The final 3D model, which also defines the domain on which COMSOL solves the
governing equations, is shown in Figure 8 (the height of the cylinder in Figure 8 is 12
mm). Note the cartilage layer shown in Figure 8. Surrounding the joint is muscle tissue
with a final outer skin layer. The diameter of the model in Figure 8 is 30mm (this value
was determined by the dimensions of the axial views in ScanIP). A cylindrical
indentation in the skin is placed in line with the joint space to mimic transducer
placement, as seen in Figure 8. Pressure acoustics is applied to the skin and muscle tissue
as linear elastic materials, and poroelastic wave theory is applied to the cartilage and
bone tissues in COMSOL modeling as has been commonly done (Baron et al., 2017).
Complete material parameters can be found in the Appendix C material.
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Figure 8: Annotated finite element COMSOL model of the rabbit knee anatomy. The space
between the femur/tibia and the inner cylinder surface is filled with muscle tissue, and the
outermost layer is skin tissue.

2.5.3 RABBIT JOINT MODEL IN 3D FREQUENCY SPACE
Preliminary modeling on the joint allowed for the final condensed geometry to be
used. Compared to the sectioned joint in Figure 7c, the final model in Figure 8 is a small
portion. COMSOL has a mesh refinement study which was used to determine how
detailed the muscle and skin tissue should be. A finer mesh was used along the centerline
of the transducer to capture in better detail the wave propagating through the joint space,
including the effects on the cartilage. The resulting mesh contains millions of elements
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and varies when different frequencies are used, since the element size is frequency
dependent.
The efficacy of ultrasound for cartilage regeneration has been much studied and
debated (Loyola-Sánchez et al., 2010). Variability of results can be explained by a
myriad of reasons, primarily that the operating frequency is non optimal. A clinical study
was done with a 1MHz pLIUS (pulsed low-intensity ultrasound) regimen which resulted
in ambiguous results (Karakaş et al., 2020). Pulsed US was applied to a general area of
the knee while flexed. When compared to patients who had no US application there were
no significant differences. Another clinical study of 1MHz was done by Loyola-Sanchez
et al. and showed promising results though further studies are required to optimize US
operations (Loyola-Sánchez et al., 2012). Theoretical modeling is a useful tool to
minimize the trial-and-error approaches to determine the optimal operating conditions.
Another reason for lower efficacy is the placement of the transducer. The placement of
the transducer must be directed by the specifics of the anatomy, in other words the MRI
should be used to choose the position where the transducer is placed. Incorrect position of
the transducer could cause a lower intensity at the defect site and the US treatment would
not induce the beneficial bioeffects (Feng et al., 2010). To summarize the factors that
played a role in the ambiguous outcomes; the frequencies which were used lay outside
the resonance range, pLIUS regimens deliver much lower pressures than cLIUS, and the
optimal placement of the transducer must depend on an individual’s anatomy.
Comprehensive modeling in COMSOL could circumvent the efficacy issues by
utilizing patient-specific anatomy. Theoretical modeling is beneficial in first deciding if
US could be therapeutic to the patient. The aim of US is to expedite the healing process
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of the tissue. Therefore, a best practice can be developed by using the COMSOL model
to study US propagation through the joint space and optimize the transducer position to
minimize the number of different tissues in the wave’s pathway and to minimize the
pathlength. Figure 9 depicts these results using the standard 1.5MHz (a-c) versus 3.8MHz
(d-f). The 3D model results are interpreted along the centerline in 2D to clearly
understand the system response at the center of the transducer.

a

b

d

e

c

f
a

Figure 9: COMSOL results from complete rabbit geometry comparing 1.5MHz US (a-c) with
3.8MHz (d-f). Panels a) and d) show the pressure propagation through the joint space on the
transducer centerline. b) and e) show the pressure field in a slice of the geometry. c) and f) show
the sound pressure level through the joint space

In further simulations using the settings obtained for a 3.8MHz transducer with 3kPa
pressure output, the position of the transducer was placed in line with the defect site (on
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the surface of the femur) to simulate the conditions which were used in rabbit
experiments. Figure 10 shows the pressure propagation results.

b

a

Figure 10: COMSOL results from complete rabbit geometry with transducer in line with femur
surface. a) shows the pressure field in a slice of the geometry where the left scale is for the bone
and cartilage and the right shows the scale for the muscle and skin. The black dot denotes where
the defect site would lie approximately. b) shows the pressure propagation along the transducer
centerline through muscle and skin (blue) and cartilage and bone (green).

As shown in Figure 10(b) there is a large difference in the pressure signal in the muscle
tissue versus cartilage and bone. The surface plot in Figure 10(a) does not show these
differences in pressure so clearly. The pressure at the surface of the cartilage tissue is
approximately 16kPa and rapidly declines to a low value that is almost not detectable
upon entering the bone. This is a result of the difference in the acoustic impedances of the
muscle, cartilage, and bone.
The pressure acoustics module in COMSOL was used to study the role of the
transducer on the pressure field in the knee, and specifically at the injury site. This was
done on a simple anatomical structure existing only of muscle and bone tissues.
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Transducer placements at the front of the knee (anterior), back (posterior), and side
(lateral) were examined where the disparity of pressure at the transducer face and the
defect site were minimized in the anterior case.
2.6 DISCUSSION OF THE 3D MODELING
Theoretical modeling in 3D gives a better understanding to what the surface of the
bone is exposed to, since its topology is not uniform. As the bone extends away from the
transducer the pressure decreases. Visualizing this in 3D is important for optimal
transducer position selection. Here the transducer has a small diameter which will not
create a uniform pressure distribution at the surface of the bone.
For future transducer selection for optimal patient applications, one must also
consider how the transducer diameter, frequency, and voltage affect the near field range.
In this range the pressure distribution is unpredictable and therefore results in variable
defect site pressures. The approximate near field distance can be calculated by (Kinsler et
al., 2000)
𝐿𝑁𝑓 = 𝑑 2 𝑓⁄4𝑢

2.6.1

where 𝑑 is the diameter of the transducer and 𝑢 is the material sound velocity. In this case
we will specify the muscle as the material as it makes up the bulk of the material in the
model. The resulting near field distance is calculated to be 24.7mm which is almost the
entire diameter of the rabbit knee. In the case of the 1.5MHz transducer, the near field is
9.8mm assuming that the diameter of the transducer is constant. Both frequency and
diameter affect the depth of the near field.
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The cLIUS results are obtained from steady state calculations. In this case, the US is
applied sufficiently long that a steady state is reached. Usually, the steady state is reached
after the wave has traversed the domain several times. In this case, the domain is threedimensional, but if you consider the direction normal to the center face of the transducer,
the distance to the knee surface is approximately 30 mm. At an approximate speed of
sound (it varies between tissue types) of 1500 m/s, it takes about 40 𝜇𝑠 to traverse the
domain twice to reach the transducer again. pLIUS treatment is a 1kHz cycle, with
200 𝜇𝑠 active and 800 𝜇𝑠 rest periods per duty cycle. Based on the estimates, about 5
passes can be fitted into one active period. All US dampens completely during the rest
period, so each active cycle will be a repeat of the previous one. Again, we iterate that the
domain is 3-D and it takes more than 5 passes to reach the steady state. In other words,
the pressures one observes with pLIUS will always be lower than the steady-state values
of cLIUS.
COMSOL is computationally much more intensive to solve the transient (i.e. pLIUS)
case. The code uses an adjustable time step, and considerably more memory is required to
integrate the equations. Just to set some perspective, it takes about 4 hours to solve the
steady state problem on the Holland computer center at UNL, but the transient problem,
modeling only the first 33 𝜇𝑠, takes more than 24 hours. Now this time does not allow for
a wave to travel across the domain and back to the transducer. Since the Biot theory is
also computationally more demanding, we were not able to model pLIUS with Biot
theory, but we had to rely on the linear elastic model. Therefore, we first ran the less
demanding steady state problem for both models. The transducer frequency is 1.5 MHz.
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The rational for this choice of frequency is the standard US application regimen is usually
done at 1.5MHz.
2.6.1 cLIUS RESULTS
In Figure 11 the steady state problem has been solved using Biot theory (left) and the
linear elastic model (right). The pressure field appears more scatted in the linear elastic
model, but more important, the range in which the pressure oscillates does not differ that
much. This point is better illustrated in Figure 12 where the pressure along the straight
line from the transducer center to the opposite free surface is plotted.

Figure 11: Comparison of the acoustic pressure field in COMSOL acoustics packages. Left:
steady-state pressure field in the knee using Biot theory. Right: steady-state pressure field using
linear elastic physics.

Figure 12: Comparison of pressure propagation along the transducer centerline. Left: The steady
state pressure vs. position, using Biot theory. Right: The steady state pressure vs. position using
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the linear elastic model. Position is measured from the center of the transducer to the opposite
free end of the knee.

The linear elastic model produces a more scattered plot, whilst one recognizes the nearfield and transition to the far-field in the Biot theory plot. Generally speaking, the
pressures are approximately five-fold higher in the linear elastic model, but this can be
explained by the fact that the Biot theory also accounts for damping in both phases,
which is not the case for the linear elastic model. Thus, we make the case that the two
models produce pressures of the same order of magnitude, factoring in the effect of
damping.

Figure 13: Enhanced steady-state pressure at the muscle-cartilage interface. Left: The steady
state pressure at the cartilage/bone interface, using Biot theory. Right: The steady state pressure
at the cartilage/bone interface using the linear elastic model.

The cartilage is only 300 𝜇𝑚 thick, which is less than one wavelength, therefore it is
more important to focus on the pressure at the muscle/cartilage interface. Although
differing quantitatively, the pressure at this interface is qualitatively similar for the two
models, albeit lower pressure for the Biot model due to damping. Therefore, we conclude
from the results in this section that Biot models and linear elastic theory give
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qualitatively similar results, and the match would be even better if damping is added to
the linear elastic model.
2.6.2 pLIUS RESULTS
As mentioned before, the pLIUS results are all based on the linear elastic model. In
the following section we will present the pLIUS results, but keep in mind that Biot results
for pLIUS are expected to look similar, but the computation is too expensive for the
available resources. In Figure 14 we show a series of snapshots at different points in time.
These snapshots provide insight of the active part of the duty cycle.

Figure 14: Panel of snapshots to show the progression of the pressure field at the start of the
active part of the duty cycle. From top left, ant-clockwise, the pressure fields are shown at 3P,
10P, 20P and 50P. P is the time of one period in the muscle, which is approximately 20 𝜇𝑠. The
position of the defect site is marked by D on the plots, and I denotes a point lying inside the bone.
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Even at 50P, the leading part of the wave has not returned from the free surface of the
knee to reach the transducer again. In other words, the incident and reflected waves have
not established a final steady state pattern. The active part is 200 𝜇𝑠, and it is expected
that the pressure field near the end of the active part will approach the steady state, since
5 passes back and forth across the centerline of the domain would be completed by then.
We can conclude from the results in Figure 14 that the pressure field builds up during
the active part of the duty cycle of pLIUS and only reaches the steady state values
towards the end of the active stage. In comparison to cLIUS, we can safely say that the
pressure field in pLIUS is significantly lower. If the pressures during the active stage are
averaged over the duration of the active part, we estimate the values are at least one order
of magnitude less than in the case of cLIUS. Therefore, from a therapeutic standpoint,
pLIUS would be less effective than cLIUS to induce the mechano-chemical reactions in
cells which lead to enhanced secretion of ECM, suppression of inflammation markers and
directing MSCs to chondrocytes.
2.7 ONE-DIMENSIONAL MODEL
The rationale for a one-dimensional model is the high computational cost associated
with the 3D model, which must be performed with licensed software on a highperformance computer. Also, the annotation of the MRI scans to demarcate the zones of
tissue/bone/muscle/cartilage is a very labor-intensive task. All these factors, in
combination, have the practical consequence that clinical applications of 3D modeling
remain a goal for the future, but in the intermediate we need to find more practical
compromises. In Figure 15 a small cylindrical domain is marked, that connect the center
of the transducer with the injury site. A one-dimensional model is used to describe the
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propagation along this cylindrical section. The model can also be used to provide an
estimate of the energy dissipation and the temperature rises along the cylinder.

Figure 15: Representation of tissue-bone-tissue domains used in 1D modeling from 3D. This
shows the transition from tissues at designated intervals where the face of the bone is in line with
the transducer. The point on the surface of the bone shows an approximate defect site.

To start the discussion, consider a one-dimensional model of US propagation through
a combination of bone and tissue. The domain is divided into tissue, 0 ≤ 𝑥 ≤ 𝐿1 , and
bone, 𝐿1 ≤ 𝑥 ≤ 𝐿2 . The transducer is placed at 𝑥 = 0, the edge of the tissue zone, and the
receiver is placed at 𝑥 = 𝐿2 . For both regions the damping is modeled by an internal
dissipation model. The dimensionless propagation models have been scaled with 𝜏 =
𝑡𝑓𝑟 , 𝑧 = 𝑥𝑓𝑟 /𝑐1 . The dimensionless domain is 0 ≤ 𝑧 ≤ 𝑧2 and the interface between the
tissue and bone region is at 𝑧2 ≤ 𝑧 ≤ 𝑧3 .The sound velocities and densities of the tissue
and bone are 𝑐1 , 𝜌1 and 𝑐2 , 𝜌2 . The reference frequency is 𝑓𝑟 = 3.8 𝑀𝐻𝑧. The
dimensionless damping coefficients are 𝛾1,2 = 𝜈1,2 𝑓𝑟 /𝑐12 .
2.7.1 NEAR-FIELD MODEL
Each point on a transducer serves as a source that transmits acoustic energy into the
space ahead of it. Depending on the geometry of the overall body within which
propagation can occur, flat-faced transducers typically transmit waves into a hemi-sphere.
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The propagation from a point source is described by the wave equation in spherical
coordinates. Using the driving radial frequency 2𝜋𝑓𝑟 = 𝜔𝑟 as a scale for time, and sound
velocity 𝑐0 to scale length, 𝜔𝑟 /𝑐0 , the equation for the radial velocity is
𝜕 2 𝑢 𝜕 2 𝑢 2 𝜕𝑢 2𝑢
𝜕 𝜕 2 𝑢 2 𝜕𝑢 2𝑢
=
+
−
+𝛾 [ 2 +
− ]
𝜕𝜏 2 𝜕𝑟 2 𝑟 𝜕𝑟 𝑟 2
𝜕𝜏 𝜕𝑟
𝑟 𝜕𝑟 𝑟 2

2.7.1

The damping coefficient depends on the kinematic viscosity 𝜈 and its dimensionless form
is 𝛾 = 𝜈𝜔𝑟 /𝑐02 . The analytical solution for a point source located at dimensionless radius
𝑅 on the transducer, the radial velocity at a distance 𝑧 from the transducer and 𝑅 = 0, is

𝑢(𝑟, 𝜏) = 𝐴𝑒

−𝑖𝜔𝜏

𝑒 𝜆𝑟 𝜆𝑒 𝜆𝑟
[ 2 −
].
𝑟
𝑟

The radius 𝑟 is 𝑟 = √(𝑅 2 + 𝑧 2 ). The dimensionless radial frequency is 𝜔 = 𝑓/𝑓𝑟 . The
wavenumber 𝜆 = 𝜆𝑟 + 𝑖𝜆𝑖 has a non-zero real part when damping is present.
1/2

−𝜔2 (1 − 𝑖𝜔𝛾)
𝜆=(
)
1 + 𝜔2𝛾 2

The velocity potential is defined as ∇u = ϕ and its solution is

ϕ = ϕ0

𝑒 𝜆𝑟−𝑖𝜔𝜏
𝑟

The pressure is
𝜕𝜙
𝑒 𝜆𝑟−𝑖𝜔𝜏
𝑃 = 𝜌0
= −𝜌0 𝑖𝜔ϕ0
𝜕𝜏
𝑟
The pressure on the transducer plate is 𝑃0 𝑒 −𝑖𝜔𝜏 .
𝑃0 = −𝜌0 𝑖𝜔ϕ0 𝜆

2.7.3
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𝑃 = 𝑃0

𝑒 𝜆𝑟−𝑖𝜔𝜏
𝜆𝑟

The pressure at point (0, 𝑧) on the centerline of the transducer is obtained from
integrating over the transducer plate;

𝑃 = 𝑃0 𝑒 −𝑖𝜔𝜏 ∫

𝑅𝑡

0

𝑒 𝜆𝑟
𝜆√𝑧 2 +𝑅𝑡2
× 2𝜋𝑟𝑑𝑟 = 2𝜋𝑃0 𝑒 −𝑖𝜔𝜏 [𝑒
− 𝑒 𝜆𝑧 ]
𝜆𝑟

𝑢(0, 𝑧, 𝜏) = 2𝜋𝐶1 𝑒

𝑖𝜔𝜏

𝑅𝑡

𝑒 −𝜆𝑟 𝜆𝑒 −𝜆𝑟
𝑧
∫ ( 2 −
) × × 𝑅𝑑𝑅
𝑟
𝑟
𝑟
0

2.7.4

A plot of 𝑅𝑒(𝑢(0, 𝑧, 𝜏)) at fixed point in time is shown in Figure 16. The constant 𝐶1 is
related to the medium sound velocity 𝑐1 , density 𝜌1 and the transducer’s delivery pressure
𝑝0 = 3𝑘𝑃𝑎:
𝑖

𝑐1 𝜌1
𝜆 𝐶 = 𝑝0
𝜔 1 1

In Figure 16 the pressure along the centerline is shown.

2.7.5
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Figure 16: (Left) Pressure along the centerline of the transducer using eq.2.7.4. The attenuation
coefficient is 𝜈 = 5 × 10−4 𝑚2 /𝑠. (Right) The pressure on the centerline, retrieved from the
solution of the 3D Biot theory model.

Both the analytical and the 3D model show the constructive/destructive interference
close to the transducer surface, but further away the 3D solution changes, due to the
complexities of the domain with scattering and reflection of waves. At the transducer
surface the pressure is 𝑝0 = 3𝑘𝑃𝑎, but it is amplified in the near-field due to the
constructive interference of the point sources to reach a maximum of 𝑃 = 26𝑘𝑃𝑎 at a
distance 3mm from the transducer (Figure 16(R)). The attenuation of the US field is a
major concern, but two points need to be considered to bring more balance to this
concern; the signal is amplified in the near-field and attenuation increases with
frequency. Overall, the Biot model exhibits stronger amplification of the signal close to
the transducer and stronger attenuation further away from the transducer, compared to the
1D model.
2.7.2 FAR-FIELD MODEL
In the case of the rabbit knee, the small transducer radius and the diminutive anatomy
have the combined effect that most of the knee lie in the near-field. However, larger
transducers will be used in human applications and it is expected that in many cases the
far-field conditions are appropriate.
Tissue
𝜕 2𝑢 𝜕 2𝑢
𝜕 3𝑢
=
+
𝛾
1
𝜕𝜏 2 𝜕𝑧 2
𝜕𝑧 2 𝜕𝜏
Bone

2.7.6
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𝜕 2𝑣
𝑐2 2 𝜕 2 𝑣
𝜕 3𝑣
=( )
+ 𝛾2 2
𝜕𝜏 2
𝑐1 𝜕𝑧 2
𝜕𝑧 𝜕𝜏

2.7.7

We kept the velocities and pressures dimensional. The pressures in the tissue and bone
regions are related to the velocities as follow;
𝜕𝑃1
𝜕𝑢
= −𝑐1 𝜌1
𝜕𝜏
𝜕𝑧

2.7.8

𝜕𝑃1
𝜕𝑣
= −𝑐22 𝜌2 /𝑐1
𝜕𝜏
𝜕𝑧

2.7.9

The solutions are;
𝑢 = 𝐶1 𝑒 𝑖𝜔𝜏+𝜆1𝑧 + 𝐶2 𝑒 𝑖𝜔𝜏+𝜆2𝑧
2.7.10
𝑣 = 𝐶3 𝑒 𝑖𝜔𝜏+𝛽1𝑧 + 𝐶4 𝑒 𝑖𝜔𝜏+𝛽2𝑧

2.7.11

The dimensionless radial frequency is 𝜔 = 2𝜋𝑓/𝑓𝑟𝑒𝑓 , the wavenumbers 𝜆, 𝛽 are
complex;
1/2

𝜆1,2

−𝜔2 (1 − 𝑖𝜔𝛾1 )
=(
)
1 + 𝜔 2 𝛾12

2.7.12

1

𝛽1,2

2
𝑐 2
−𝜔2 ((𝑐2 ) − 𝑖𝜔𝛾2 )
1
)
=(
𝑐2 4
2
2
(𝑐 ) + 𝜔 𝛾2
1

2.7.13

If the damping coefficients were zero, then 𝜆1 = 𝑖𝜔, 𝜆1 = −𝑖𝜔 and 𝑢𝐹 = 𝐶2 𝑒 𝑖𝜔(𝜏−𝑧) and
𝑢𝑅 = 𝐶1 𝑒 𝑖𝜔(𝜏+𝑧) are easily identified as the forward and backward propagating wave.
This distinction still holds for the damped case, 𝑢 = 𝑢𝐹 + 𝑢𝑅 .
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The boundary condition at 𝑧 = 0 describes the external forcing.
𝑖

𝑐1 𝜌1
(𝜆1 𝐶1 + 𝜆2 𝐶2 ) = 𝑃0
𝜔

2.7.14

At 𝑧 = 𝑧1 , continuity of 𝑢 and 𝑃 is imposed;
𝐶1 𝑒 𝑖𝜔𝜏+𝜆1𝑧1 + 𝐶2 𝑒 𝑖𝜔𝜏+𝜆2𝑧1 = 𝐶3 𝑒 𝑖𝜔𝜏+𝛽1𝑧1 + 𝐶4 𝑒 𝑖𝜔𝜏+𝛽2𝑧1
𝐶1 𝜆1 𝑒

𝑖𝜔𝜏+𝜆1 𝑧1

+ 𝐶2 𝜆2 𝑒

𝑖𝜔𝜏+𝜆2 𝑧1

𝜌2 𝑐22
=
(𝐶3 𝛽1 𝑒 𝑖𝜔𝜏+𝛽1𝑧1 + 𝐶4 𝛽2 𝑒 𝑖𝜔𝜏+𝛽2𝑧1 )
𝜌1 𝑐12

2.7.15
2.7.16

At 𝑧2 a stress-free condition is applied.
When another tissue region is added behind the bone, 𝑧2 ≤ 𝑧 ≤ 𝑧3 , similar continuity
conditions are imposed at the second interface 𝑧2 and the stress-free condition is applied
at 𝑧3 . In Table 3 parameter values are listed for the examples which are presented next.
Longitudinal sound

Density, 𝜌

Thermal conductivity,

velocity, c (m/s)

(kg/m3)

k (W/mK)

Tissue 3,500

1550

1073

0.7

Bone

3844

1900

0.56

Type

𝐶𝑃 (J/kg K)

1,260

Table 3: Parameter values for tissue and bone.

In Figure 17 the velocity and pressure are shown in the tissue-bone-tissue domain for
𝛾1 = 𝛾2 = 0.0028. The frequency is 𝑓 = 3.8 𝑀𝐻𝑧 = 𝑓𝑟 . The width of each region is set
to approximate values obtained from rabbit MRIs with distances of 5𝑚𝑚, 12 𝑚𝑚, and
30𝑚𝑚.
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Figure 17: Velocity and pressure in the tissue-bone-tissue domain at f = fr.

The largest velocity decrease occurs in the first tissue region and is negligible in the
bone region. The pressure amplitude also drops in the first tissue region, no change in the
bone region and a notable reduction when the second tissue region is entered. Next, we
consider a similar configuration at 𝑓 = 1.5𝑀𝐻𝑧 in Figure 18.
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Figure 18: Velocity and pressure in the tissue-bone-tissue domain at f = 1.5MHz.

The dampening is much lower than for the previous case. The drops in particle
velocity occurs at the tissue/bone, while we see a decreased velocity and pressure in the
second tissue domain. When the damping coefficients in the tissue is increased tenfold,
for 𝛾1 = 10𝛾2 = 0.028, the pressure and velocity are strongly damped in the first region,
despite the fact that the frequency is f =1.5MHz. The results are shown in Figure 19.
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Figure 19: Velocity and pressure in the tissue-bone-tissue domain at f = 1.5MHz for increased
𝛾1 .

Next the damping coefficient in the bone is increased tenfold, 10𝛾1 = 𝛾2 = 0.028.
The results are shown in Figure 20. The damping is much weaker in the first tissue
region, and the pressure in the second bone region is also much stronger, although the
damping coefficient in the bone region is tenfold higher.
The overall trends are that the damping coefficient of the tissue is the most important
factor that affects the intensity of the US field throughout the domain. Secondly, and
consistent with internal damping mechanisms, stronger damping occurs at higher
frequencies.
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Figure 20: Velocity and pressure in the tissue-bone-tissue domain at f = 1.5MHz for increased
𝛾2 .

If the objective of an US therapy is to deliver US to an injury site at 𝑧1 , i.e. the
interface of the first tissue region and the bone, then the damping in the first tissue region
plays the key role in determining the US intensity at the treatment site. As shown in
Figure 19, the US is almost completely annihilated in the bone and second tissue region,
but there is still a good field strength at 𝑧1 . Note in this case the frequency is f = 3.8MHz .
The analysis clearly demonstrates that it is very misleading to assess the US intensity
at 𝑧1 , based on measurements at 𝑧3 . Oftentimes researchers will place a receiver at 𝑧3 to
compare the input with the signal at the other end of the domain. This underscores the
importance of the model.
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Figure 21: Velocity and pressure in the tissue-bone-tissue domain at f=fr for increased 𝛾2 .

2.7.3 ENERGY DISSIPATION
Damping is an irreversible energy transfer from the US field to the internal energy of the
material (bone or tissue). The rate of dissipation is
𝑊1 = 𝛾1 𝑓𝑟 𝜌1 𝑢̅2

2.7.17

𝑊2 = 𝛾2 𝑓𝑟 𝜌2 𝑣̅ 2

2.7.18

and
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And 𝑢̅2 , 𝑣̅ 2 denote the forward and reverse components of the velocity in each region,
multiplied with their complex conjugates. In Figure 22 the dissipation and pressure are
shown for 𝛾1 = 0.0014, 𝛾2 = 0.0028 and 𝑓 = 𝑓𝑟 .

Figure 22: Dissipation rate and pressure in the tissue-bone-tissue domain at f= fr with damping
coefficients 𝛾1 = 0.0014 𝑎𝑛𝑑 𝛾2 = 0.0028.

The dissipation rate is largest next to the transducer, from where it decays exponentially,
the rates are low in the bone and second tissue regions.
The temperature is scaled with the ambient temperature, 𝜃 =

𝑇−𝑇𝑎𝑚
𝑇𝑎𝑚

the first tissue

region is described by the following equation. The radial variable has also been scaled
with 𝑓𝑟 /𝑐1 .
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𝜕𝜃1 𝜅1 𝑓𝑟 𝜕 2 𝜃1 1 𝜕
𝜕𝜃1
𝑊1
(𝑟
)] +
= 2 [ 2 +
𝜕𝜏
𝑟 𝜕𝑟
𝜕𝑟
𝜌1 𝐶𝑝1 𝑇𝑎𝑚 𝑓𝑟
𝑐1 𝜕𝑧

2.7.19

= 𝐴1 Δ𝜃1 + 𝐵1 𝐴1 𝑊1
The domain that is considered for the temperature distribution consists of a cylinder
with radius 𝑅𝑐 (the scaled radius of the transducer), and a cylindrical annulus surrounding
it where into thermal energy conducts. The US dissipation rate is zero for 𝑟 > 𝑅𝑐 . From
Figure 22 one infers that 𝑊𝑖 = 𝑊𝑖0 𝑒 −𝑎𝑖 𝑧 , 𝑖 = 1,2,3. In Table 4 we list some of the
dimensionless parameters including the dissipation rates from Figure 22.
Region

𝜅𝑖

𝐴𝑖

𝐵𝑖

𝑊𝑖0,

𝑎𝑖

Tissue, i=1

2.2 E-07

3.0 E-07

9.9 E-10

13,574

0.0178

Bone, i=2

2.4 E-07

3.3 E-07

1.2 E-09

3,436

0.0303

Tissue, i=3

2.2 E-07

3.0 E-07

9.9 E-10

960

0.0361

Table 4: Dimensionless parameter values.

2.7.4 THERMAL GENERATION
The maximum temperature is at the center, which lies along 𝑧 ≥ 0, and 𝑟 = 0.
Consider the steady state problem, and as a first approximation we have lumped the
radial conduction as follows;
𝑑2 𝜃1𝑠
− 𝐶1 𝜃1𝑠 + 𝐵1 𝑊1 = 0,
𝑑𝑧 2

0 ≤ 𝑧 ≤ 𝑧1

𝑑2 𝜃2𝑠
− 𝐶2 𝜃2𝑠 + 𝐵2 𝑊2 = 0,
𝑑𝑧 2

𝑧1 ≤ 𝑧 ≤ 𝑧2

𝑑2 𝜃3𝑠
− 𝐶3 𝜃3𝑠 + 𝐵3 𝑊3 = 0,
𝑑𝑧 2

𝑧2 ≤ 𝑧 ≤ 𝑧3
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At 𝑧 = 0, 𝜃1𝑠 = 0 ,and at 𝑧 = 𝑧3, 𝜃3𝑠 = 0. At 𝑧 = 𝑧1,2 we impose continuity of
temperature and thermal flux,
𝜃1𝑠 = 𝜃2𝑠 , 𝑧 = 𝑧1
𝑑𝜃1𝑠 𝑘2 𝑑𝜃2𝑠
=
, 𝑧 = 𝑧1
𝑑𝑧
𝑘1 𝑑𝑧
𝜃2𝑠 = 𝜃3𝑠 , 𝑧 = 𝑧2
𝑑𝜃3𝑠 𝑘2 𝑑𝜃2𝑠
=
, 𝑧 = 𝑧2 .
𝑑𝑧
𝑘1 𝑑𝑧

The solutions are

𝜃1𝑠 = ℎ11 𝑠𝑖𝑛ℎ(√𝐶1 𝑧) +

𝐵1 𝑊10
𝐵1 𝑊10 −𝑎 𝑧
𝑐𝑜𝑠ℎ(√𝐶1 𝑧) − 2
𝑒 1
2
𝑎1 − 𝐶1
𝑎1 − 𝐶1

𝜃2𝑠 = ℎ21 𝑠𝑖𝑛ℎ(√𝐶2 𝑧) + ℎ22 𝑐𝑜𝑠ℎ(√𝐶2 𝑧) −

𝐵2 𝑊20 −𝑎 𝑧
𝑒 2
𝑎22 − 𝐶2

𝜃3𝑠 = ℎ31 𝑠𝑖𝑛ℎ(√𝐶3 𝑧) + ℎ32 𝑐𝑜𝑠ℎ(√𝐶3 𝑧) −

𝐵1 𝑊30 −𝑎 𝑧
𝑒 3
𝑎32 − 𝐶3

The coefficients ℎ𝑖𝑗 are determined by applying the boundary conditions. In Figure 23 the
temperature rise along the centerline is shown for 𝐶1 = 𝐶2 = 0.01 (top) and 𝐶1 = 𝐶2 = 0
(adiabatic case).
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Figure 23: Temperature rise in the tissue-bone-tissue domain at f = fr. The damping coefficients
are 𝛾1 = 0.0014 𝑎𝑛𝑑 𝛾2 = 0.0028. The top panel corresponds to C1 = C2 =0.01 and the bottom
panel to the adiabatic case (C1,2=0).

The adiabatic temperature is an upper bound of the system. The adiabatic
temperature rise is 0.035℃ and the maximum lies in the second tissue region. The nonadiabatic temperature rise (𝐶1,2 = 0.01) is approximately 0.005℃ and the maximum lies
near the center of the first tissue region.
To summarize, a 1-D model has been developed that describes the US field in a
system comprising of regions of tissue and bone. The model includes dissipation of the
US field. The dissipation is a source term in the thermal energy balance and estimates of
the temperature rise can be derived for adiabatic and non-adiabatic conditions. One utility
of the model is to vary the input pressure until a target pressure is observed at the
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interface of the first tissue region and the bone (presumably the site of injury). The
concomitant adiabatic temperature rise can be compared to temperature rises which are
considered physiologically safe.
2.8 ANIMAL MODEL
The work done here was a collaborative effort with many different parties. Animal
surgeries and procedures were designed by Dr. Anu Subramanian, and performed by Dr.
Craig Kreikemeier-Bower. Histological analyses were done by University of AlabamaBirmingham Dr. Oraine Snaith, and Dr. Gene Siegal. Animal care and US application
was done at University of Nebraska-Lincoln in Veterinary Sciences by Katelin Oborny
and Jesse Baumann-Berg. The following results are a cumulative effort from all
acknowledge parties and under publication preparation.
2.8.1 RABBIT CARTILAGE DEFECT MODEL
Bilateral defects were created on the knees of the rabbits using an IACUC approved
protocol (1297) at the University of Nebraska-Lincoln (Lincoln, NE). To exclude genderbased differences in animal response to injury and repair, female New Zealand Rabbits
(white), less than 8-months of age with a body weight of 4kg or less were purchased and
acclimatized for about a week prior to surgery. Rabbits were anesthetized by the
administration of Ketamine IM (35mg/kg) and xylazine (5mg/kg). Gas anesthesia was
maintained using a nose-cone supplying 2-3% isoflurane. Rabbits were laid in supine
position on the operating table and the knee was shaved and sterilized using betadine and
2% chlorhexidine. A medial parapatellar approach was used to enter the knee joint placed
in flexion of 70 degrees and the patella was dislocated laterally to expose the articular
surface of the distal femur. The defect was created on the medial femoral condyle as
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follows: A 5-mm diameter, full thickness cartilage defect was created using a biopsy
punch (Miltex, York, PA) and a curette was used to remove the cartilage and the calcified
layer thoroughly. Microfracture to a 3mm depth was performed using a surgical drill
mounted with 0.9mm K-wires to create three 1.5mm diameter holes in each defect site,
with each hole being 2 to 2.5mm apart on the subchondral bone (Figure 24A). Our
rationale for going 3mm deep is based on a previous study that demonstrated that a 3mm
deep hole significantly enhanced the volume of blood that could ooze from the bone
marrow without penetrating the epiphyseal scar (Figure 24B) (Truong et al., 2014).
Saline was continuously flushed to minimize the heat caused by drilling. The joint was
then irrigated using saline and inner dermis was sutured using biodegradable suture while
the outer dermis was closed using nylon sutures and/or metal staples which were
removed after a week. Animals were monitored for complications by research and
veterinary staff.

Figure 24: (A) A biopsy punch was used to circumscribe the defect area on the femoral medial
condyle and a curette was used to debride the cartilage to create a full thickness cartilage defect.
A surgical drill outfitted with 0.9mm K-wire was used to create 2.5 to 3 mm deep holes into the
subchondral bone to induce bleeding into the defect. (B) Representative image of the defect
created. (C) cLIUS was applied via a handheld transducer.
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2.8.2 ANIMAL HOUSING AND CARE
Following the surgery, all animals received pain medication (Buprenorphine SR)
during the surgical procedure and meloxicam every 24 hours for at least two days. After
two days, if the animals showed any of the signs of pain or distress, Buprenorphine SR or
meloxicam was administered on an as needed basis. As an antibiotic, enrofloxacin was
given prophylactically once daily, starting intra-operatively and then 3 days postoperative. Rabbits were all housed together on the floor and were allowed unrestricted
activity post-operatively. All rabbits were analyzed in a long-term study for 8 weeks. A
total of 12 animals were included in these studies.
2.8.3 US APPLICATION PROCEDURE
US was applied using a custom-made non-focused transducer (Olympus NDT Inc.,
MA) with a radiating area of 1.27cm2, a center frequency that matches the in-vivo
resonant frequency identified (~3.8MHz), and a duty cycle of 100% (Figure 24C). All
transducers were characterized by the manufacturer prior to usage. A waveform generator
(HP, 33120A) was used to generate LIUS at the frequency of 3.8 MHz. The transducer
was positioned on the skin such that the transducer face was approximately in line with
the defect area. Coupling gel was applied to the skin. In the absence of exhaustive clinical
literature from which to make absolute estimations of treatment time, current literature
justifies one minute of US energy per treatment head area covered (Watson, 2008). US
was applied for eight minutes/day for five days/week beginning on postoperative day 3.
The sites were periodically shaved to ensure contact between the transducer, coupling
gel, and skin, and the rabbits were held in a baby carrier.
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At 8-weeks following defect creation, rabbits were anesthetized and euthanized as per
the approved IACUC protocol. Following euthanasia, both stifle joints were harvested to
allow visual inspection, X-ray analyses, and histopathologic testing of the repair tissue
including the surrounding cartilage, the tibial cartilage in contact with the repair tissue
and similar tissues from the contralateral limb.
2.8.4 IN VIVO EVALUATION OF CLIUS IN A FULL THICKNESS ARTICULAR
CARTILAGE DEFECT RABBIT MODEL TREATED WITH
MICROFRACTURE
Bi-lateral defects were created on the femoral medial condyle and left knee joint was
subjected to the cLIUS treatment where the contralateral right joint served as the control
(Figure 25). During defect preparation, immediate bleeding from the underlying
subchondral bone plate was always observed after microfracture (Figure 24B). When the
animals were euthanized at 4 or 8 weeks postoperatively, no joint effusion, macroscopic
inflammation, peri-articular osteophytes, and adhesions were noticed in all treated joints.
Three rabbits developed swollen joints post-surgically which were managed by draining
the synovial fluid and administration of approved analgesics. Upon the completion of an
8-week study, all the rabbits appeared to have full range of motion in both knees and
none of the rabbits developed apparent joint degradation or synovial inflammation.
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Figure 25: Rabbit-matched images of the defect areas are shown. Defect area is shown by a
dotted circle. Panel-A shows the defect area created on the right femoral medial condyle on the
day of surgery prior to closing of the joint fascia. Panel-B shows the defect area upon joint
retrieval. Panel-C shows the defect area created on the left femoral medial condyle on the day of
surgery prior to closing of the joint fascia. Panel-D shows the defect area upon joint retrieval.
Panel-E shows the digital X-rays taken post euthanasia using a portable machine from
Diagnostic Imaging Systems Inc (Model EPX-F2800).

Post euthanasia, joint capsule was opened, photographed, and evaluated
macroscopically (Figure 25). In the non-stimulated control joints, defects were still
obvious, with defect boundaries still visible exhibiting noticeable color and texture
differences within the surrounding cartilage (Figure 25B). In contrast, the left knee joint
that received cLIUS treatment showed uniform tissue fill in most defects with similar
color and texture within the surrounding cartilage (Figure 25D). Macroscopic evaluation
indicated integration of the engineered tissue with the native cartilage. Previous research
showed that therapeutic doses of US (<500 mW/cm2 ) did not have an adverse effect on
bone growth or led to degeneration of the cartilaginous cells in the growth plate (Lyon et
al., 2003). Anteroposterior (AP) and lateral radiographs (LP) of each knee joint were
obtained after euthanasia and analyzed. Therapeutic doses of US (<500 mW/cm2) did not

65

have an adverse effect on bone growth or cause degeneration of the cartilaginous cells in
the growth plate. As anticipated, no adverse impact on the bone or changes within the
joint space were noted under cLIUS (< 20 mW/cm2) employed in this study (Figure
26Figure 25).
Representative rabbit matched staining for hematoxylin and Eosin (H&E), Safranin-O,
and IHC for collagen II (COL-II) are shown in Figure 26.

Figure 26: Histological evaluation of rabbit knee joint sections at 8 weeks. Upon joint retrieval,
rabbit joints were fixed in 10% formalin and processed for histological analyses using standard
procedures. Left knee joints (C-D) were treated with cLIUS and the right knee joints (A-B) served
as the contralateral non-stimulated control. 4 to 6 µm sections were stained and presented.
Images at 2x and 20x magnifications are included and scale bars are shown in the images. PanelA and C shows the HE stained section of a representative right and left rabbit joint, respectively.
Panel-B and D shows the Safranin-O stained section of a representative right and left rabbit
joint, respectively.

Qualitative assessment of the H&E-stained histological sections of the non-stimulated
right knee joints revealed incomplete filling of defects, loss of cellularity, and increase in
subchondral bone density as a result of the reparative process and, in some cases, an
irregular cartilage surface was noted (Figure 26A). Little to no staining for
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glycosaminoglycans (GAGs, Safranin-O) was observed in the defect area of the right
knee joints (Figure 26B). In some sections, a loss of Safranin-O staining in the superficial
layer of the surrounding native cartilage was noted indicating a loss of the extra cellular
matrix components. Defects in the left knee joints treated with cLIUS showed a complete
fill level to the surrounding native cartilage and a positive staining for GAGs matched the
surrounding undamaged cartilage (Figure 26C and Figure 26D). Additionally, a rounded
chondrocyte-like morphology, columnar organization and some cell clustering was
observed.
2.9 CONCLUSION
All the information provided on the importance of transducer selection highlights
theoretical modeling significance in cartilage regeneration. From the placement of the
transducer to the input voltage, optimal selections can result in tissue repair or minimal
effects due to a variety of variables. In some cases a patient could even see
disadvantageous effects such as tissue damage due to unstable intensity. Avoiding this
could be easily done through theoretical modeling on a patient-by-patient case. A
summary of the main findings from this chapter are:
•

There exists a linear relationship between input voltage and output pressure of
a transducer.

•

Comparing pLIUS and cLIUS shows that pLIUS always results in lower
pressures, and thermal generation of cLIUS is not significant enough to rise
concern for tissue health.

•

Transducer placement is key in optimal pressure seen at the surface of the
bone. When the transducer is in line with the joint space US penetrates deeply,
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whereas when the transducer is in line with the defect site US minimally
penetrates but a larger pressure is seen due to reflection of the US signal.
•

A 1D model shows similar results to that of the 3D model and is significantly
less computationally expensive. This would be the optimal model for patientspecific treatments in clinical settings.

•

Performing a rabbit study using 3.8MHz cLIUS as a cartilage defect
reparative therapy resulted in effective cartilage repair without exogenous
addition of growth factors.
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CHAPTER 3 – PERICELLULAR MATRIX MODEL
3.1 INTRODUCTION
Tissue regeneration can occur after damage due to the natural occurrence of stem
cells throughout the human body (Facchin et al., 2018). An exception to this remarkable
feature is articular cartilage, due to its avascular nature (Fox et al., 2009). The building
blocks of cartilage, chondrocytes, are embedded in a mesh prohibiting the cells to move
to the injured site (Newman, 1998). This essential connective tissue has a low friction
coefficient and thus is an essential tissue which is located between joints that supports
and distributes forces during everyday motion (Wilusz et al., 2014, Han et al., 2012).
Everyday activities over time as well as injury and obesity can damage this essential
tissue causing a negative response in the chondrocyte and surrounding area (Guilak et al.,
2004). Damaged articular cartilage leads to degradation and subchondral bone
remodeling which translates to pain and dysfunction in the joint (Chen et al., 2013).
These defects lead to the disease known as osteoarthritis, affecting millions of people per
year (Arden, Nevitt, 2006; London et al., 2011). The necessity of cartilage tissue for
health of joints merits research on methods to replace or renew it. Current methods of
regeneration are vast and include: microfracturing (Mithoefer et al., 2009), grafting
(Rubak et al., 1982), synthetic scaffold resurfacing (Sams, Nixon, 1995), autologous
chondrocyte implantation (Richardson et al., 1999), and stem cell implantation
(Mardones, Larrain, 2016; Freitag et al., 2016). These methods are expensive, invasive,
and have conflicting efficacy (Huey et al., 2012; Kon et al., 2012) often requiring a
combination of therapies to be used (Pestka et al., 2011). Result from these methods are
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unsatisfactory requiring an alternative solution. A worthy candidate for non-invasive
technique for cartilage regeneration comes from a method that has already been proven to
work for bone fracture treatment: low-intensity ultrasound.
A chondron consists of the pericellular matrix (PCM) surrounding the chondrocyte(s)
(Benninghoff, 1925). The PCM surrounding the chondrocyte consists of an organized
structure of types II, VI, and IX collagen as well as proteoglycans such as aggrecan,
decorin, fibronectin, and hyaluronan (Poole et al., 1988). These molecules play a role in
regulating biological functions protecting the chondrocyte from apoptosis (Wilusz et al.,
2014; Mow et al., 1999; Haider et al., 2006). The structure of the PCM acts as a buffer
between the chondrocyte and the extracellular matrix (ECM) to filter out mechanical
forces as well as molecules entering or exiting the chondrocyte (Zhang, 2015; Zelenski et
al. 2015), thus regulating cell activity (Wilusz et al., 2014; Guilak et al., 2006). Within
the PCM it has been shown that chondrocytes occupy a low volume of cartilage tissue
(Poole et al., 1997), layered with varying cell morphology and different nutrient
requirements. Deformation experiments have shown the chondrocyte to change
morphology under pressure, but to return to normal when unapplied (Wang et al., 2010).
The PCM acts in a protective role thereby reducing stress on the chondrocyte. Parameters
from Haider et al based on chondron osmotic loading experiments were used here
(Haider et al., 2006). In past research individual chondrocytes have been modeled in an
acoustic field exhibiting multiplicity (Miller et al., 2017). This study expands the
nonlinear model from the chondrocyte to the chondron by including the surrounding
PCM as a dampening factor. In this study we present a model of the interactions of a
force on the PCM in the classical wave equation with a viscoelastic model of two phases.
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3.2 INTRODUCING THE MATHEMATICAL MODEL FOR THE PCM
Inclusion of the PCM adds another layer that must be penetrated by ultra-sound (US)
waves before they impact on the chondrocytes themselves. A chondron, of radius 𝑅𝐶 , is
surrounded by a PCM layer of radius 𝑅𝑃 .
In the following section we first analyze the PCM. The PCM is a biphasic material,
consisting of a solid phase and a liquid phase. The momentum balances for the solid and
liquid phases are:

(𝜆 + 2𝜇)

𝜕 1 𝜕 2
𝜕𝑃
𝜕𝑢
𝜕 2𝑢
( 2 (𝑟 𝑢)) − 𝜙
+ 𝐾 (𝑣 − ) = 𝜌𝑠 2
𝜕𝑟 𝑟 𝜕𝑟
𝜕𝑟
𝜕𝑡
𝜕𝑡

3.2.1

𝜕𝑃
𝜕𝑢
𝜕𝑣
− 𝐾 (𝑣 − ) = 𝜌𝑓
𝜕𝑟
𝜕𝑡
𝜕𝑡

3.2.2

and

−(1 − 𝜙)

where 𝑟 is radius, 𝜙 is the solid volume fraction, 𝑃 is pressure, 𝑢 is the solid
displacement, 𝑣 is the fluid velocity, 𝐾 is a diffusive drag coefficient, and 𝜌𝑠 and 𝜌𝑓 are
the solid and fluid densities. The term (𝜆 + 2𝜇) is called the aggregate modulus where
both 𝜆 and 𝜇 are dependent on the Young’s modulus E and Poisson ratio 𝜐 such that 𝜇 =
𝐸
2(1+𝜐)

𝐸𝜐

and 𝜆 = (1+𝜐)(1−2𝜐). Note that we neglect the nonlinear convection term in eq.
𝜕𝑣

3.2.2 (i.e. 𝜌𝑣 𝜕𝑟) as is the practice in the derivation of linear acoustic wave propagation.
First, we assume the densities of the solid and fluid phases to be close. The continuity
equation for the PCM is;
1 𝜕 2
𝜕𝑃
(𝑟 [(1 − 𝜙)𝑣 + 𝜙𝑢̇ ]) = −𝐴
2
𝑟 𝜕𝑟
𝜕𝑡

3.2.3
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3.2.1 DIMENSIONLESS MODEL FOR THE PCM
The liquid velocity and solid displacement are scaled with the sound velocity of the
liquid phase and the chondrocyte radius as follows:
𝑊 = 𝑣⁄𝑐
𝑠 = 𝑢/𝑅𝐶
The scaled pressure is given by
𝜋 = 𝑃/(𝜌𝑓 𝑐 2 )
The radial variable 𝒓 is scaled with 𝑅𝐶 and time 𝑡 is scaled with 𝑅𝐶 /𝑐.
The balancing equations in dimensionless form are;
𝜕 2 𝑠 2 𝜕𝑠 2𝑠
𝜕𝜋
𝜕𝑠
𝜕 2𝑠
+
−
−
𝜙𝛼
+
𝛼
[𝑊
−
]
=
𝛼
1
2
3
𝜕𝜌2 𝜌 𝜕𝜌 𝜌2
𝜕𝜌
𝜕𝜏
𝜕𝜏 2
−(1 − 𝜙)

𝜕𝜋
𝜕𝑠
𝜕𝑊
− 𝛽1 [𝑊 − ] =
𝜕𝜌
𝜕𝜏
𝜕𝜏

1 𝜕
𝜕𝑠
𝜕𝜋
(𝜌2 [(1 − 𝜙)𝑊 + 𝜙 ]) = −𝐴
2
𝜌 𝜕𝜌
𝜕𝜏
𝜕𝜏
The dimensionless parameters are:

𝛼1 =

𝜌𝑓 𝑐 2
𝐾𝑐𝑅𝐶
𝜌𝑠 𝑐 2
𝐾𝑅𝐶
; 𝛼2 =
; 𝛼3 =
; 𝛽1 =
(𝜆 + 2𝜇)
(𝜆 + 2𝜇)
(𝜆 + 2𝜇)
𝜌𝑓 𝑐

Note: The parameter 𝐴 in eq. 3.2.6 is a dimensionless constant.

3.2.4

3.2.5

3.2.6

72

3.2.2 CASE 1: INCOMPRESSIBLE FLOW
𝜕𝜋

Let us assume incompressibility (i.e. 𝜕𝜏 = 0 in eq. 3.2.6). After integrating the
𝜕𝑠

continuity equation, we find the relation between 𝜕𝜏 and 𝑊 depends on the function 𝐵(𝜏):

𝑊=
Next we substitute for

𝜕𝜋
𝜕𝜌

−𝜙 𝜕𝑠
1
𝐵(𝜏)
+
(1 − 𝜙) 𝜕𝜏 (1 − 𝜙) 𝜌2

3.2.7

from eq. 3.2.5 into eq. 3.2.4 and replace 𝑊 using eq. 3.2.7.

Since the system is externally forced the forcing will determine the temporal behavior.
𝜕 2 𝑠 2 𝜕𝑠 2𝑠
𝐵(𝜏)
+
−
+
𝜅
𝑠
=
𝜅
1
2
𝜕𝜌2 𝜌 𝜕𝜌 𝜌2
𝜌2

3.2.8

The new constants are
𝜙 2
𝜙𝛼1 𝛽1
𝑖𝜔
) 𝛼1 + 𝛼3 ] 𝜔2 − (
)
𝜅1 = [(
+ 𝛼2 ) (
1−𝜙
1−𝜙
1−𝜙
𝜙𝛼1 𝛽1
1
𝜙𝛼1 𝛽1 𝜔
)−𝑖
𝜅2 = − (
+ 𝛼2 ) (
(1 − 𝜙)2
1−𝜙
1−𝜙
The homogeneous solutions are

𝑠ℎ = 𝐴 (

𝑠𝑖𝑛(𝑎𝜌)
𝑐𝑜𝑠(𝑎𝜌)
𝑐𝑜𝑠(𝑎𝜌)
𝑠𝑖𝑛(𝑎𝜌)
−𝑎
)+𝐵(
+𝑎
)
2
2
𝜌
𝜌
𝜌
𝜌
𝑎3

3.2.9

The Wronskian is 𝑤 = − 𝜌2 , and it is not zero on the interval 𝜌 ∈ [1, 𝑅𝑝 /𝑅𝐶 ]. The
particular solution is
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𝑠𝑝 = −

𝜅2 𝐵0 𝑠𝑖𝑛(𝑎𝜌) 𝑠𝑖𝑛(𝑎𝜌)
𝑐𝑜𝑠(𝑎𝜌)
(
−𝑎
)
3
2
𝑎
𝜌
𝜌
𝜌
3.2.10
𝜅2 𝐵0 𝑐𝑜𝑠(𝑎𝜌) 𝑐𝑜𝑠(𝑎𝜌)
𝑠𝑖𝑛(𝑎𝜌)
+ 3
(
+
𝑎
)
𝑎
𝜌
𝜌2
𝜌

The general solution is the sum of the homogeneous and the particular solutions. The
boundary conditions are applied to the general solution. Before we include the PCM layer
in the nonlinear cell model, let us analyze it by itself. Therefore, we impose the following
boundary conditions at the inner and outer PCM surfaces;
𝑠 = 𝑠0 𝑒 𝑖𝜔𝜏 , 𝜌 = 𝑅𝑃 /𝑅𝐶
𝑠 = 0, 𝜌 = 1.
We consider external forcing at the outer surface. By setting the displacement equal
to zero at the inner surface, we calculate the maximum normal stress, proportional to

𝜕𝑠
𝜕𝜌

,

that the PCM will exert on the chondrocyte. In Figures Figure 27 - Figure 29 we compare
the normal stress at the outer PCM surface (blue) with the stress at the inner surface (red)
for three different values of the damping coefficient 𝐾. The plots in Figure 27 represent a
case of moderate damping, 𝐾 = 1010 𝑃𝑎. 𝑚2 /𝑠, and the plots in Figure 28 and Figure 29
are calculated for 𝐾 = 1011 𝑃𝑎. 𝑚2 /𝑠 and 𝐾 = 1012 𝑃𝑎. 𝑚2 /𝑠 respectively.
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Figure 27: Plots of the time dependence of ∂s/∂ρ at the outer PCM surface (blue) and inner PCM
surface (red). K is 1010 Pa m2/s.

The first interesting observation is that the stress is higher at the inner surface than at
the outer surface – this is not that surprising since we are dealing with a spherical
coordinate system. Also note that a small phase shift exists between the two waves.
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Figure 28: Plots of the time dependence of

𝜕𝑠
𝜕𝜌

at the outer PCM surface (blue) and inner PCM

surface (red) for a damping coefficient of 1011 Pa m2/s.

The phase shift has increased from the plots in Figure 27 and the damping effect more
than cancels the focusing effect of the spherical coordinate system. The ratio of the input
normal stress to output normal stress (blue: red amplitudes) is less than one. The damping
mechanism converts the input mechanical energy into thermal energy and less
mechanical energy is available at the inner PCM surface.
In Figure 29 we plot the results for 𝐾 = 1012 𝑃𝑎. 𝑚2 /𝑠. The system becomes
overdamped, as a matter of fact the system is dominated by the parabolic terms and the
mechanical forcing decays monotonically. This represent a case where all the input
mechanical energy is converted into thermal energy. Depending on the energy input, this
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situation could lead to significant temperature rises. The results in Figure 29 are
representative of all damping coefficients higher than 1012 𝑃𝑎. 𝑚2 /𝑠.

𝜕𝑠

Figure 29: Plots of the time dependence of 𝜕𝜌 at the outer PCM surface (blue) and inner PCM
surface (red) for a damping coefficient of 1012 Pa m2/s.

3.2.3 CASE 2: A > 0
The collagen fibers which constitute the solid phase of the PCM are submicron
particles which will exhibit very little inertia, particularly at the US frequencies we use in
our studies. Therefore, we do not expect much slip to occur at the interface of the two
𝜕𝑠

phases. To put it in more quantitative terms, let 𝑊 − 𝜕𝜏 = 𝑔𝑊, where 𝑔 ≪ 1, 𝑔 > 0.
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𝜕𝑠

Thus, we substitute for 𝜕𝜏 in eq. 3.2.6. The scaling we have used leads to 𝐴 = 1. Next we
eliminate the pressure between equations 3.2.5 and 3.2.6 and obtain the classical wave
equation with a damping term.
𝜕 2 𝑊 2 𝜕𝑊 2𝑊
𝜕𝑊 𝜕 2 𝑊
(1 − 𝜙𝑔) [ 2 +
− 2 ] − 𝛽1 𝑔
=
𝜕𝜌
𝜌 𝜕𝜌
𝜌
𝜕𝜏
𝜕𝜏 2

3.2.11

The solution consists of spherical Bessel functions of the first and second kind
𝑠𝑖𝑛(𝑎𝜌)
𝑐𝑜𝑠(𝑎𝜌)
𝑐𝑜𝑠(𝑎𝜌)
𝑠𝑖𝑛(𝑎𝜌)
𝑊 = [𝐵1 (
−𝑎
) + 𝐵2 (
+𝑎
)] 𝑒 𝑖𝜔𝜏
2
2
𝜌
𝜌
𝜌
𝜌

3.2.12

The wavenumber is complex;
𝑎2 = (𝜔2 − 𝑖𝛽1 𝑔𝜔)/(1 − 𝜙𝑔).
The constants 𝐵1,2 are defined by the external forcing. Suppose the pressure on the outer
surface of the PCM layer is 𝜋0 𝑒 𝑖𝜔𝜏 , then we can examine the solution with varying
damping coefficients shown by Figures Figure 30 and Figure 31.
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Figure 30: Plot of the solution to the wave equation with varying damping coefficient 1010 Pa
m2/s.

Figure 31: Plot of the solution to the wave equation with varying damping coefficient 1011 Pa
m2/s.
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3.3 DISCUSSION
Presented here is a model showing the effects of outside pressure application to the
PCM and the signal translated to the chondrocyte. The results clearly show the
importance of the magnitude of damping coefficient used in the wave equation. This
model was prompted from the radial biphasic model from Haider where the damping
coefficients were much higher in magnitude causing an overdamped system and little
transmission of signal to the chondrocyte (Haider, 2004). The mechanical signal seen
through actin and collagen fibers in the PCM surrounding the cell activates
autoregulation in cartilage, and when stem cells are present stimulate chondrogenic
differentiation (Zhao et al., 2020). A high damping coefficient correlates with an
overdamped system which in turn transforms the mechanical energy into thermal energy.
Too much heat in the system causes apoptosis.
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CHAPTER 4 – PATHWAYS IN CHONDROGENESIS
4.1 INTRODUCTION
Frictionless movement in joints is due to the cushion articular cartilage provides on
the end of long bones. Cartilage tissue is essential to everyday movement ranges in
thickness and mechanical properties (Guilak et al., 2005). Breakdown and degradation of
this tissue can be attributed to age and joint stress via trauma and/or obesity, resulting in
osteoarthritis, a chronic joint condition (Setton et al., 1999). This degenerative disease
affects millions of people per year and is becoming more commonplace with the rise of
aging and obese populations. The lack of this protective tissue causes pain and irritation
in surrounding tissues and inevitably leads to bone loss (Han et al., 2019). Chondrocytes
are the cells that maintain and makeup cartilage tissue which rely on the dense
extracellular matrix for signals and nutrients since the tissue is avascular (Hunziker et al.,
2002).
The nature of cartilage tissue lacks the capability for self-renewal or regeneration,
requiring outside interventions (Grande et al., 1989). Various clinical approaches for
tissue repair have been explored, though typically a full joint replacement is the answer.
With the ever-increasing population requiring intervention for cartilage tissue loss,
research has heightened to find more effective reparative techniques (Boushell et al.,
2017). One such method is a minimally invasive option utilizing a microfracture
procedure with continuous low intensity ultrasound (Qi et al., 2011). Ultrasound
treatment has proven to heal bone fractures, promote pain relief, and reduction of muscle
spasms (Pilla et al., 1990, Morishita et al., 2014). Microfracture allows a blood source
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needed for the avascular tissue to heal. The small channels, or stents, created during
microfracture allow for bone MSCs to migrate to the injured bone surface where cartilage
tissue is needed. Synovial fluid surrounds the joint and provides nutrients for cartilage
and thus MSCs for chondrocyte formation (O’Hara et al., 1990).
The process of MSC differentiation to a chondrocyte (chondrogenesis) which occurs
in stages: recruitment and migration, proliferation, and condensation (Goldring et al.,
2006). Chondrogenesis is a complex and multistep process that begins by migrating and
condensing MSCs (Goldring et al., 2005). Different markers in varying concentration
correspond to the stages of chondrogenesis which is taken into consideration in the
following modeling sections. This study focuses on the condensation of MSCs – an
important indicator of differentiation to chondrocytes. The condensation stage peaks at
day 3 (Bang et al., 2000) which could be expedited by utilizing ultrasound. In vitro
experiments show cellular condensation leading to chondrogenesis in monolayer cultures
(Shukunami et al., 2009). Three dimensional alginate cultures have also demonstrated
condensation of rabbit bone marrow MSCs and subsequent induction of cartilage matrix
synthesis under cLIUS at 1MHz (Lee et al., 2007). Furthermore, cell condensation was
demonstrated in vitro providing significant evidence toward chondrogenic development
(Kim et al., 2016; Sing, Schwarzbauer 2014). More evidence of condensation during
chondrogenesis through pLIUS has been shown in vitro and in vivo experiments (Uenaka
et al., 2009).
Many studies have suggested that LIPUS treatment is conducive for regenerating
articular cartilage, despite the fact that the underlying mechanisms tying intracellular
pathways to improved, healthier outcomes remain poorly understood (Chen et al., 2017).
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There exists ample evidence (Louw et al., 2013; Sahu et al., 2020) that US promotes the
expression of SOX9 in chondrocytes, which lead to higher levels of ECM secretion.
Putative intracellular pathways responsible for the upregulation of SOX9, initiated by US
stimulation have been proposed by Louw et al. and Miller et al. (Louw et al., 2013;
Miller et al., 2017). They also conjectured on the mechano-chemical mechanisms.
Briefly, two mechanisms have been proposed which work in parallel. First, US causes
oscillating widening/contracting of the calcium ports in the cell membrane, and the
increase in calcium in the cell triggers the mitogen-activated protein kinase (MAPK)
pathway (Raizman et al., 2010). The second mechanism, admittedly speculative, is that
US also causes a dilatational expansion/contraction of the cell nucleus and this action
could lead to faster nuclear translocation. Important evidence that supports this
mechanism was reported by Whitney et al. (Whitney et al., 2012). This work linked the
nuclear transport and chromatin binding to mechanical energy density of the nucleus
using a combination of modeling and in vitro experiments.
Although chondrocytes are responsible for the formation of new cartilage and the
maintenance of ECM, the broader physiological picture must include the recruitment of
mesenchymal stem cells (MSCs) from the bone marrow to the injured site where they
differentiate into chondrocytes to supplement the existing cells and aid in the healing
process. Chondrogenesis is therefore an important part of the repair process. A very
interesting finding, reported by Lee et al., is that US also promotes chondrogenesis (Lee
et al., 2006). To put this finding in perspective, in vitro studies on chondrogenesis always
require that MSCs be treated with exogeneous transforming growth factor beta (TGF-β),
a growth factor that is a necessary precursor to differentiate to chondrocytes. In the in
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vivo case, the exogeneous prompting is obviously absent, which means the MSCs
produce them endogenously. Coming back to the result of Sahu et al., who compared in
vitro chondrogenesis of MSCs exposed to US with non-US controls (Sahu et al., 2020).
The MSCs which were exposed to US readily differentiated into chondrocytes but the
controls did not. It is conjectured that the signaling pathway starts via mechanical stress
that is mediated by integrins (Whitney et al., 2012), from pressure signals in the
surrounding matrix. The mathematical model here attempts to describe the condensation
stage of chondrogenesis in MSCs by tying together the essential pathways and the
subsequent changes in protein expression levels.
4.2 PATHWAYS INVOLVED IN CHONDROGENESIS
Extensive research of molecular regulation on MSC differentiation has shown that
MAPKs, TGF-, and Wnt signaling are essential for chondrogenesis (Guo, Wang, 2008)
with the most widely studied pathway being the MAPK/ERK cascade due to the integrin
receptors being thought of as primary regulators. The ability of integrin receptors to
communicate with surrounding matrix elements is seen in mechanotransduction studies
and confirms the necessity to describe the cascade as a whole (Zhao et al., 2020). Of the
many proposed pathways that exist in chondrogenesis (Li, Dong, 2016), three are
highlighted to here to be essential in the condensation process: the focal adhesion kinase
(FAK) pathway, TGF-β pathway, and the wingless-type protein (Wnt) pathway
(Szychlinska et al., 2017). The TGF-β pathway expresses the transcription factor SOX9,
a master marker for mesenchymal cell commitment to chondrogenic lineage (Coricor,
Serra, 2016). Chondrogenesis is a multifaceted process which also includes pathway
crosstalk. This can be seen with the proposed interactions shown in Figure 32.
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Figure 32: Simplified view of proposed mechanisms within the FAK, TGF-, and Wnt pathways.

4.3 ON MODELING EFFECTS FROM ULTRASOUND
In an effort to understand the effects of ultrasound treatment researchers have relied
on in vitro experiments (Korstjens et al., 2008; Whitney et al., 2012). This provides some
understanding of just how ultrasound effects these chondrocytes such as inhibition of
inflammatory responses (Sahu et al., 2019). Chondrocytes are surrounded by a
pericellular matrix (PCM) as well as an extracellular matrix (ECM) which dampen the
mechanical signals to the chondrocyte. The deformation in the surrounding matrices
gives rise to a response in the chondrocyte by stimulating pathway initiation and
releasing factors from receptors (Zhao et al., 2020). Integrin receptors are transmembrane
proteins that mediate chemical and mechanical signals from outside and inside the cell
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via attachments to actin filaments (Ingber, 1991). This makes integrins a high interest
study area due to the interest in their interactions with the ECM. The focus here is their
ability to translate the mechanical signals from ultrasound to stimulate activation of the
FAK pathway.
Though it is known that US effects the FAK pathway, reports of altering other
pathways have been found (Huang et al., 2018). For the TGF- pathway it was found to
initiate the expression of TGF- without any exogenous additions (Lee et al., 2006).
More specifically the induction of condensation has been widely achieved by chemical
and physical stimuli for chondrogenic differentiation with the TGF- pathway (Pelaez et
al., 2012). These are taken into account in the following sections, which describe the
mathematical interpretation of US effects on each pathway and include the responses
from pathway crosstalk.
4.3.1 THE FAK PATHWAY
The most widely studied pathway in chondrogenesis is the focal adhesion kinase
(FAK) pathway, which is the upstream regulator of the MAPK pathway. Multiple
inhibition experiments show that integrin mediated interaction is key in condensation and
chondrogenesis (Bang et al., 2000; Zhang et al., 2015). FAK and the cytoskeleton protein
paxillin are essential for precartilage condensation of MSCs. Phosphorylation of FAK
showed to be increased during condensation, and subsequently reduced as
chondrogenesis progressed. Inhibiting treatments showed markedly suppressed
condensation and cartilage nodule formation indicated phosphorylated FAK is required.
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Condensation of MSCs with ultrasound begins with the focal adhesion kinase (FAK)
pathway through mechanosensitive integrin receptors. FAK is an essential tyrosine
protein for integrin signaling shown to be a key factor in a variety of pathways (Parkin et
al., 2019). This model focuses on the activation of a complex bound to integrins in the
cytoplasm which begins the cascade where phosphorylation of Ras, Raf, MEK1/2, and
ERK1/2 leads to cell growth and proliferation (Zhou et al., 2015). This pathway overall
has been shown to be an important intracellular mediator of chondrocyte differentiation
through the extracellular signal-related kinase (ERK) (Bobick, Kulyk, 2004).
A 2015 model by Zhou et al. examined pulsed low-intensity ultrasound (pLIUS)
effects on fibroblast cells using Michaelis Menten kinetics (Zhou et al., 2015). This study
showed integrin receptor activation with the Rho/ERK signaling pathway. This model
was combined with nuclear shuttling modeling done by Fujioka et al. to create a
complete picture of the pathway (Fujioka et al., 2006). Ultrasound starts the cascade on
the FAK pathway by forcing the integrins on the cell wall apart using an equation relating
work done on the environment, an initial reaction rate 𝑘0 , and the mean Gibbs free
energy to create an opening between integrins (Dudko et al., 2006):
1

1/𝜈
𝜈𝑤 𝜈−1 Δ𝐺[1−(𝜈𝑤
) ]
Δ𝐺
𝑘 = 𝑘0 (1 −
)
𝑒
Δ𝐺

Work on the system can be defined as a quasi-static process of cellular contraction (Dill
et al. 2010):
𝑉𝐵

𝑤 = − ∫ 𝑃𝑑𝑉
𝑉𝐴
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From previous modeling on the PCM we assume a symmetrical pressure of 10kPa.
The change in volume under an external pressure is set to 2e-15m3 (Guo et al., 2017).
Pathway kinetics are modeled using Michaelis-Menten as well as first or second order
reactions. The FAK model by Zhou et al. used experiments to verify that ERK activation
with ultrasound promotes cell proliferation (Zhou et al., 2004). To fully describe this
pathway, a model elucidating Ras-Raf signaling from Fujioka et al. has been incorporated
(Fujioka et al., 2005). They used fluorescent probes to determine rate constants for use in
their mathematical model primarily using first and second order reactions. This showed a
peak activation of RasGTP at five minutes and thereafter a steady decline.
4.3.2 THE TGF- PATHWAY
Wide agreement has been reached on the requirement of TGF- for all stages of
chondrogenesis (Chen et al., 2009). TGF- acts as a multifunctional remodeling growth
factor and modulator of gene expression (Huang, Chen, 2012). This pathway creates the
master chondrogenic marker SOX9. The TGF- pathway promotes cartilage matrix
synthesis in various stages of chondrogenesis through the creation of TGF- and the
master chondrogenic marker SOX9. Although the gene expression from this pathway is
essential, it alone is not enough to explain chondrogenesis due to the reduced TGF- and
type II receptor in older patients (Qureshi et al., 2008). Exogenous TGF- experiments
with pLIUS shows chondrogenic differentiation of MSCs in alginate culture (Lee et al.,
2006), stimulated TGF- production (Mukai et al., 2005), and SOX9 level dependency
on pathway crosstalk activation via dynamic compressive forces (Haudenschild et al.,
2010). The results lead to a hypothesis that pLIUS utilizes multiple pathways. Those

88

findings translate to cLIUS as similar mechanical signals are sent to the chondrocyte
through the surrounding matrices
Nuclear phosphorylated Smad2/3 increases levels of SOX9 which leads to the
chondrogenic markers collagen 2 and aggrecan (Cleary et al., 2013). These components
have repeatedly been proven essential in chondrogenesis which are described here with
TGF- and receptor levels as they correlate directly to pathway activity (Liu et al., 2018).
Sustained TGF- stimulation with medium-dosing has been well described by Zi et al.
(Zi et al., 2011). This pathway has been incorporated to the overall model, with initiating
kinetics changed to be based on US stimulation in a fashion similar to that of the FAK
pathway, and modified TGF- kinetics using knowledge that phosphorylated Smad2/3
mediates transcription of intracellular TGF- which secrets to the extracellular
environment (Morshed et al., 2018). A report using bone cells with continuous lowintensity ultrasound (cLIUS) application at 3MHz showed an increase of more than 2fold at minimum from initial concentration (Harle et al., 2005). Since osteoblasts are
closely related to chondrocytes, utilizing this information serves as a basis for the effect
of US on chondrocytes (Findlay, Atkins, 2014).
4.3.3 THE WNT PATHWAY
The final pathway integrated here is the Wnt canonical pathway, otherwise called the
-catenin pathway. Conflicting evidence of the role of Wnt signaling in chondrogenesis
has been reported (Ham et al., 2015), but in recent years has been identified as playing a
central role in cellular mechanotransductive responses (Bullock et al., 2018). This could
be due to the wide variety of ligands, receptors, and co-receptors that exist in the Wnt
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family and the complex nature of the pathway (Abuammah et al., 2018). Through
experimentation Wnts 3a, 4, 5a, 5b, 7a, 11, and 14 have been all been found to play a role
in MSC condensation (Hens et al., 2009) as well as all other stages of chondrogenesis
(Gadjanski et al., 2012).
A quantitative model of the Wnt pathway was published by Lee et al. (Lee et al.,
2003) where the dishevelled receptor was activated which in turn releases GSK3B from
the APC/Axin/GSK3B complex continuing on to a cyclical destruction of catenin/APC/Axin/GSK3B and the phosphorylated complex. This cycle includes catenin and its phosphorylated state interacting with Axin and APC. The pathway ends in
nuclear -catenin/TCF which serves as a transcription activator. The intracellular
downstream signaling molecule in this pathway, -catenin, plays a mediating role in the
canonical pathway and is shown to be a transcriptional co-activator in the proliferation
and differentiation of MSCs (Day et al., 2005). Variation of -catenin levels show
changes in gene expression therefore requiring modeling to show optimal levels for
chondrogenesis. In osteoblast cells mechanical loading and shear stress have been shown
to activate canonical Wnt signaling (Olkku et al., 2010). With the unique structure of the
dishevelled receptor, the US activation of this pathway has to be adjusted. This was done
by increasing the rate of activation of the dishevelled receptor (Betancourt et al., 2012).
4.4 PATHWAY CROSSTALK
Findings have usually focused on the primary pathway, and no consideration has been
given to the interaction with other signaling cascades. With our better understandings of
how the primary pathway works, research on crosstalk between pathways has shown
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more complex interactions (Oshimori, Fuchs, 2012). Studies on pathway interactions also
vary with reports of inhibition or enhancement. The majority of variability can be
attributed to the cell type used in experiments. Expression of SOX9 and aggrecan were
significantly down-regulated with ERK inhibiting experiments during dynamic
compression confirming that ERK activation is key for chondrogenesis to occur (Pelaez
et al., 2012). Instead, cells are driven towards osteogenic lineage. ERK is a multifaceted
protein and involved in various signaling pathways and it was also taken into account in
this model.
4.4.1 FAK AND WNT
The original Wnt pathway developed by Lee was expanded to include ERK activation
through crosstalk (Kim et al., 2007). Their model uses a positive feedback loop with an
unknown molecule X, and influenced by Raf kinase inhibitor protein (RKIP). The results
show stimulation from an inactive to active state without any external receptor signaling
from growth factors. Here the model has been adjusted to be activated through the ERK
activation from the FAK pathway. Further confirmation of synergistic interaction
between these pathways has been proven to exist in osteoblasts (Sun et al., 2016).
Experiments showed a direct correlation of FAK deficiency translating to downregulation
of the canonical Wnt signaling.
4.4.2 FAK AND TGF-
The precise role of ERK activation in research has been described in both positive
(Xu et al., 2020) and negative (Li et al., 2010) roles regarding chondrogenesis. This
system describes ERK activation as a positive regulator in chondrogenesis as activation
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of ERK results in increased TGF- levels (Pelaez et al., 2012). Research done on cells of
mesenchymal origin show synergistic ERK-Smad interactions (Hayashida et al., 2003).
Furthermore, experiments with chondrogenic specificity also show synergistic effects of
TGF- and integrin mediated signaling that enhance downstream signaling during
condensation with cartilage nodule formation (Bang et al., 2000). The tight coupling of
these two pathways is has been well established experimentally (Furumatsu et al., 2005).
Hough et al. suggested a positive scheme in MSCs coupling these two pathways where
instead of inhibitory effects, the interacting proteins enhance kinetics (Hough et al.,
2012). Here, the TGF- receptor I interacts with RasGDP to shift to the GTP state.
Another possible interaction between the pathways is phosphorylated ERK assisting in
nuclear translocation of phosphorylated Smad2/3 (Javelaud, Mauviel, 2005).
4.4.3 WNT AND TGF-
The TGF- pathway promotes Wnt activity through decreasing Axin expression
which increases Wnt ligand expression (Wu et al, 2016). A positive feedback loop has
been identified by Seo et al., showing that TGF- induces Wnt production (specifically
Wnt3a) (Seo et al., 2019), which increases TGF- production, and so on in cardiac
fibroblasts which has been confirmed in chondrocytes (Zhou et al., 2009). Here, the
proposed mechanism of TGF- activation of the Wnt pathway is through the
phosphorylated Smad2/3 Smad4 complex with cytoplasmic -catenin increasing the
nuclear translocation to -catenin/TCF (Wu et al., 2016). General activation of the Wnt
pathway through exogenous additions of TGF- has been shown in fibroblasts through
accumulation of nuclear -catenin, leading to the transcription coactivator -catenin/TCF

92

(Akhmetshina et al., 2012). The other part of the positive feedback loop involves Axin
from the Wnt pathway activating Smad2/3 through the TGF- receptor I (Furuhashi et
al., 2001). Overall, high levels of -catenin are shown in mesenchymal condensation with
increased SOX9 expression (Kirton et al., 2007).
4.5 RESULTS AND DISCUSSION
The modeling done here focuses on three primary pathways to show protein levels
directly associated with chondrogenic specific markers during condensation. The
mathematical model was built utilizing powerful ODE solvers in Matlab. The three
models from Zhou et al., Zi et al., and Kim et al. are combined here with crosstalk in
pathways to build the full model. One of the key takeaways from inhibition experiments
is the intricacy of underlying events during MSC differentiation. The plots here are in
nanomolar concentrations, with time in seconds. Pulsed ultrasound (pLIUS) experiments
showed a threefold increase of FAK phosphorylation at 3.5MHz (Jang et al., 2014). Here,
we see a similar response at 3.8MHz in Figure 33.
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Figure 33: Phosphorylated FAK levels as a direct result of implementing force functions on the
integrin receptor via FAK kinetics. Concentration is measured in nanomolar on the y-axis while
time is measured in seconds on the x-axis.

The beginning of the Ras/Raf cascade is induced by the GDP to GTP exchange of Ras,
which can be observed by the change seen in Figure 34. The GTP state of Ras is a
mediator in crosstalk with the Wnt pathway which should therefore be examined.
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Figure 34: Activated Ras (RasGTP) levels during US stimulation. Concentration is measured in
nanomolar on the y-axis while time is measured in seconds on the x-axis.

Phosphorylation of ERK was shown to slightly increase at the end of pLIUS
application and eventually peaked at a 2.26-fold increase 10-20 min after stimulation
(Zhou et al. 2004). The model here was run for the entire eight minutes of cLIUS
stimulation where a 1.26-fold increase was observed, seen in Figure 35 (a) along with all
overall ERK configurations (b).
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Figure 35: Phosphorylated ERK (pERK) and ERK changes. Concentration is measured in
nanomolar on the y-axis while time is measured in seconds on the x-axis.

The changes in the TGF- pathway can be seen by the changes in Smad2/3 levels.
This is monitored throughout the US stimulation by Figure 36. Time is shortened here to
better show how rapidly Smad levels are depleted.
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Figure 36: Phosphorylated Smad2/3 and phosphorylated nuclear Smad2/3 levels during US
stimulation. Concentration is measured in nanomolar on the y-axis while time is measured in
seconds on the x-axis.

Finally, we can see the changes in the Wnt pathway. Accumulation of -catenin is shown
by Figure 37(a), while the transcriptional coactivator can be seen in (b). These levels are
similar to those seen in modeling done by Kim et al., though the time to reach these
levels are reduced due to US stimulation increasing reaction kinetics within the pathway
(Kim et al., 2007).
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Figure 37: Levels of -catenin. Concentration is measured in nanomolar on the y-axis while time
is measured in seconds on the x-axis.

Overall, these model results show that ultrasound stimulation results in faster kinetics in
intracellular pathways.
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4.6 CONCLUSION
The three models utilized here have provided a basis for the beginning stage of
chondrogenesis, condensation. Individually these models are well established from in
vitro experiments to show their necessity during condensation. Through research
applying mechanical stress to cells, it has been well shown that cells utilize force sensors
in a variety of ways through adhesion-associated proteins that activate downstream signal
pathways (Cheng et al., 2017). Here we show the effects of cLIUS on key pathways
during MSC condensation resulting in multi-fold increases in protein levels. These levels
have been confirmed through individual pathway models, and tied together here through
proposed crosstalk rate kinetics in similar magnitudes. These findings are consistent with
the mechano-sensing function of FAK holding a critical role in membrane
mechanotransduction (Zhou et al., 2015).
Further experimentation could lead to a more accurate model as well as a better
understanding of the interactions of the pathways. Higher accuracy could also be attained
in the sole use of MSCs during in vitro experiments to further show US effects on these
pathways. This model describes the TGF- receptors in a similar fashion to the FAK
receptors. This conclusion was reached as integrins are key mechanisms in extracellular
TGF- activation (Angelini et al., 2020).
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CHAPTER 5 – FUTURE DIRECTIONS
The work presented here was based on rabbit experiments done to show the effects of
continuous pulsed ultrasound on cartilage tissue. It expands on previous experimental
findings and two-dimensional modeling. Further expansion in modeling should be done
to better describe the viscoelastic behavior of muscle tissue in the in vivo model. Clinical
protocols utilizing US for therapy has shown variable results; this could be due to lack of
application optimization which should be examined.
The 3D modeling environment here is described with linear elastics and attenuation
coefficients found from literature. This analysis shows a good basis for future models to
be built upon. Muscle is described as a viscoelastic material, and can be accounted for in
other packages in COMSOL. Attenuation coefficients could also easily be confirmed or
found in simple laboratory experiments. The overall goal is to determine efficient energy
coupling to the cell which enhances bioeffects in the cell. A large scale model in the 3D
environment incorporating cells in the cartilage tissue layer should be further studied.
The biopsy punch model here was a good start to that, though in the 3D environment
could become more computationally expensive than models already run.
5.1 HUMAN APPLICATION OF cLIUS
Limited human applications of ultrasound for cartilage regeneration have been done
thus far. Human biology is larger in scale to rabbit including larger muscle and fat mass.
The effect of this on ultrasound applications has not been investigated theoretically. A
complete model including all tissues would give better insight to exactly how the
macroscopic system responds to US stimulation.
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Clinical protocol development is the desired result from research. The results here
indicate that MSCs after microfracture procedures should utilize a frequency of 2.1MHz
applied for only the first two days. After that time period, interchanging with 3.8MHz
should be done to decrease inflammation markers. From the third day on the treatment
should be switched completely to 3.8MHz. Our animal models were done for 8min/day,
for 5days/week. The time applied should be confirmed or optimized in additional studies.
5.2 ALL-INCLUSIVE PATHWAY MODEL
The comprehensive pathway model included here only describes the first stage of
chondrogenesis marked by specific protein expressions. Ideally future work would focus
on confirming US effects to each pathway and obtaining more accurate kinetic data.
Kinetic data here was obtained by a variety of cell types. Future experiments should
utilize one type – preferably human bone marrow-derived MSCs.
Expanding the model would have to include piecewise functions to signal the start of
other pathways important in later stages of chondrogenesis. Those pathways and ion
channels would have to be included in what is already a large model, and shortening each
pathway would be necessary for computational restraints. Each pathway should be
examined in the in vitro environment with cLIUS application to observe its effects on
protein expression levels.
There is some speculation on the mechanisms which US effects nuclear shuttling of
cytoplasmic proteins. This should further be studied to examine just how that occurs.
Whether it be increased kinetics from upstream US modulation, or a function of US akin
to the mechanosensing description of FAK.
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APPENDIX A: NOMENCLATURE AND ABBREVIATIONS
Pore Size
𝑎
ACI
Autologous Chondrocyte Implantation
ACL
Anterior Cruciate Ligament
ALK1
Activin Receptor-Like Kinase 1
APC
Adenomatous Polyposis Coli
Speed of Sound
𝑐
Complex Speed of Sound
𝑐𝑐
cLIUS
Continuous Low-Intensity Ultrasound
COL2A1 Type II Collagen
Heat Capacity
𝐶𝑃
Diameter
𝑑
DICOM
Digital Imaging and Communications in Medicine
DZ
Deep Zone
DZP
Different Zonal Properties
ECM
Extracellular Matrix
Young’s Modulus
𝐸𝑑
ERK
Extracellular Signal-Related Kinase
Viscous Drag
𝐹
Body Load Source Term
𝑭
Frequency
𝑓
FAK
Focal Adhesion Kinase
FE
Finite Element
Reference Frequency
𝑓𝑟
GSK3B
Glycogen Synthase Kinase 3 Beta
Identity Tensor
𝑰
IFNγ
Type II Interferon
IL-1
Interleukin-1
IL-1β
Interleukin-1 Beta
IL-6
Interleukin-6
Wave Number
𝑘
Wave Vector
𝐤
Drained Bulk Modulus
𝐾𝑑
K
Diffusive Drag Coefficient
KLM
Krimholtz Leedom Matthaei
kPa
Kilopascal
Biot Module
𝑀
MHz
Megahertz
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mm
MMP13
MRI
MSC
MZ
𝑁
𝐧𝐤
OA
P
P
PCM
𝑝𝑓
pLIUS
𝑝0
𝑝𝑡
𝑟
𝑅𝐶
𝑅𝑝
SOX9
SZ
SZP
TGF-β
TNFα
𝒖
𝒒𝑑
𝑄𝑚
US
Vpp
𝒘
Wnt

Millimeter
Matrix Metallopeptidase 13
Magnetic Resonance Image
Mesenchymal Stem Cell
Middle Zone
Number of Elements
Normal Unit Vector
Osteoarthritis
Period
Pressure
Pericellular Matrix
Pore Pressure
Pulsed Low-Intensity Ultrasound
Pressure Amplitude
Total Pressure
Radius
Chondrocyte Radius
Pericellular Matrix Radius
SRY-Box Transcription Factor 9
Superficial Zone
Same Zonal Properties
Transforming Growth Factor Beta
Tumor Necrosis Factor Alpha
Porous Material Displacement
Source Vector
Monopole Source Term
Ultrasound
Peak to Peak Voltage
Fluid Displacement
Wingless Type Protein

𝛼𝐵
𝜅
𝜇̃𝑓

Biot-Willis Coefficient
Permeability
Frequency-Dependent Viscosity

𝜇𝑓
µm
µs
𝜈𝑑

Dynamic Fluid Viscosity
Micrometer
Microsecond
Poisson’s Ratio
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𝜌
𝜌𝑎𝑣
𝜌𝑐
𝜌𝑑
𝜌𝑓

Density
Average Density
Complex Density
Porous Matrix Density
Fluid Density

𝜌𝑠
𝜏
𝜏¥
𝑢
𝜙
𝜔
𝝈
𝝐
𝜖𝑝

Solid Density
Dimensionless Time
Tortuosity
Material Sound Velocity
Solid Volume Fraction
Angular Frequency
Cauchy Stress Tensor
Strain Tensor
Porosity
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APPENDIX B: KLM EQUIVALENT MATHEMATICS
The basic structure of the KLM model derived by Krimholtz-Leedoem-Matthaei
can be seen by Figure 1 in the main text. Equivalent circuit parameters are described by
equations B1.2 through B1.4. The components in the model utilize the
B1.1
𝑍0 = 𝜌𝑃𝑍𝑇 𝑐𝑃𝑍𝑇 𝐴
where 𝜌𝑃𝑍𝑇 , 𝑐𝑃𝑍𝑇 , and 𝐴 are density, speed of sound, and area of the piezoelectric
element,
𝐶0 = 𝜀𝐴/𝑑
where 𝜀 is the permittivity of the piezoelectric element, and 𝑑 is its thickness,

B1.2

2
B1.3
ℎ33
𝑠𝑖𝑛(𝜔𝑑/𝑐𝑃𝑍𝑇 )
2
𝜔 𝑍0
where ℎ33 is the electromechanical constant and 𝜔 is the angular frequency, and finally:

𝑋1 =

𝜔𝑍0
B1.4
2ℎ33 sin(𝜔𝑑/2𝑐𝑃𝑍𝑇 )
These equations are used to determine the impedance values at the front and back of the
transducer, detailed in Figure 1.
𝜙=

APPENDIX C: COMSOL PARAMETERS
For the Suspended Cell Model
Variable

Symbol

Radius (µm)

r

Young’s Modulus (kPa)

E

Porosity

ε

Poisson’s Ratio

σ

Permeability (m2)

κ

MSC
Nucleus Cytoplasm
7.1
11.25
(Stachecka (Kreuger
et al.,
et al.,
2018)
2018)
4.7 (Ruiz
9.07 (Ruiz
et al.,
et al.,
2012)
2012)

0.5 (Ruiz
et al.,
2012)

Blood
Clot
32.5

5.3
(Mfoumou
et al.,
2014)
0.19
(Wufsus
et al.,
2013)
0.49
(Mfoumou
et al.,
2014)
6.7E-15
(Wufsus
et al.,
2013)

Chondrocyte
Nucleus Cytoplasm
3.5
6.5 (Miller
(Miller et et al.,
al., 2017) 2017)

PCM

ECM

9 (Miller et
al., 2017)

32.5 (Miller
et al., 2017)

34.7
(Alexopoulos
et al., 2003
)
0.83 (Haider,
2004)

1.3[MPa]
(Alexopoulos
et al., 2003
)
0.83

0.38
0.43
(Miller et (Haider,
al., 2017) 2004)

0.04 (Haider,
2004)

0.04

7e-19
7e-19
(Miller et (Miller et
al., 2017) al., 2017)

0.76e-16
(Alexopoulos
et al., 2003
)

9e-16
(Alexopoulos
et al., 2003
)

1 (Haider,
2004)

0.65
0.75
(Miller et (Miller et
al., 2017) al., 2017)
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Density (kg/m3)

ρ

Bulk Modulus (Pa)

K

Shear Modulus (Pa)
Biot-Willis Coefficient

G
α𝐵

1.08E3 (5) 400
(Miller et
al., 2017)
E/3(1-2σ) 2e3
(Miller et
al., 2017)
E/2(1+σ)
0.9996
(Miller et
al., 2017)
2

300 (Miller
et al.,
2017)
500 (Miller
et al.,
2017)

0.9999
(Miller et
al., 2017)
Tortuosity
τ
1.2 (Miller
et al.,
2017)
Dynamic Viscosity
μ
0.003
0.7e-3
0.7e-3
(Pa*s)
(Miller et (Miller et
al., 2017) al., 2017)
Compressibility of Fluid
4.32E-10
4.35e-10 4.35e-10
χ𝑓
(1/Pa)
(Wang et
(Miller et (Miller et
al., 2001) al., 2017) al., 2017)
Any values not input for the MSC are made the same as the values for the chondrocyte.

E/3(1-2σ)

E/3(1-2σ)

E/2(1+σ)
0.99749

E/2(1+σ)
0.9058

3.4e3
(Nguyen et
al., 2010)

3.4e3
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For the 3D Model
Variable
Symbol Skin
3
Density (kg/m )
ρ
1020 (Liang et al.,
2009)
Speed of Sound
c
1645 (Moran et al.,
(m/s)
1995)
Young’s Modulus
E
(Pa)
Poisson’s Ratio
σ

Muscle
1073
(Kuthe,
Uddanwadiker, 2016)
1550 (Feigin et al., 2020)

Cartilage
1470 (Basser et al.,
1998)
1640 (Toyras et al.,
2003)
1e6 (Guo et al., 2013)

Bone
1900 (Cameron et al.,
1999)
3700 (Cameron et al.,
1999)
7.3e9
(Franciosa,
Gerbino, 2010)
0.125 (Korhonen et al., 0.3 (Franciosa, Gerbino,
2003)
2010)
Biot-Willis
0.875
(COMSOL, 0.15 (Smit et al., 2002)
α𝐵
Coefficient
2018)
Porosity
ε
0.75 (Hosoda et al., 0.05 (Cardoso et al.,
2009)
2013)
2
Permeability (m )
κ
2.6e-14 (Hosoda et al., 2.2e-7 (Smit et al.,
2009)
2002)
Tortuosity
τ
1
1.05 (Fellah et al., 2004)
Using the Pressure acoustics physics on the skin and muscle only requires density and speed of sound to be specified for the materials
it is applied to.
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APPENDIX D: KINETIC EQUATIONS IN PATHWAYS
Rate constant values used in pathway model.
Units

Value

s-1
s-1
(nMs)-1
s-1
s-1
(nMs)-1
(nMs)-1
s-1
(nMs)-1
(nMs)-1
nM
(nMs)-1
(nMs)-1
(nMs)-1
(nMs)-1
(nMs)-1
(nMs)-1
(nMs)-1
(nMs)-1
(nMs)-1

9.33
9.33
0.09
9.33
9.33
0.09
6
0.3
0.003
0.003
340
0.003
0.0015
0.03
0.01
0.021
0.0045
0.01
0.009
0.12

Units

Value

nM
nM
s-1

0.132
0.132
0.6

s-1
s-1
(nMs)-1
s-1
s-1
nM s-1
s-1
s-1
s-1
s-1
s-1
s-1
s-1
s-1
s-1

0.09
0.06
0.0009
0.05
0.1
1.7
0.1
0.0001
0.064
0.06
0.1
0.03
0.0214
0.0429
0.000214

𝑘1
𝑘2𝑚
𝑘3𝑚
𝑘4𝑏

𝑘7𝑏
𝑘8𝑏
𝑘9𝑏
𝑘10𝑏
𝑘11𝑏
𝑉12𝑚𝑎𝑥
𝑘13𝑏
𝑘14𝑏
𝑘15𝑏
𝑘16𝑏
𝑘17𝑏
𝑘18𝑏
𝑘19𝑏
𝑘20𝑏
𝑘21𝑏
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𝑘2𝑐𝑎𝑡
𝑘3𝑐𝑎𝑡
𝑘4
𝑘5𝑐𝑎𝑡
𝑘6𝑐𝑎𝑡
𝑘7
𝑘8
𝑘9
𝑘10
𝑘11
𝑘12𝑚
𝑘13
𝑘14
𝑘15
𝑘16
𝑘17
𝑘18
𝑘19
𝑘20
𝑘21

𝑘22
𝑘23𝑚
𝑘24
𝑘25
𝑘26
𝑘27
𝑘28
𝑘29
𝑘30
𝑘31
𝑘32
𝑘33
𝑘34
𝑘35
𝑘36
𝑘37
𝑘38
𝑘39
𝑘40
𝑘41
𝑘42
𝑘𝑑𝑒𝑔𝑇1𝑅
𝑘𝑑𝑒𝑔𝐿𝑅𝐶

s-1
nM
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
μM s-1
min-1
-1

min

-1

(nMmin)

𝑘𝑖

-1

min

0.00256
0.0137
0.333

𝑘22𝑚
𝑉23𝑚𝑎𝑥
𝑘24𝑏
𝑘25𝑏
𝑘26𝑏
𝑘27𝑏
𝑘28𝑏
𝑘29𝑏

nM
nM s-1
s-1
s-1
s-1
s-1
s-1
s-1

0.181
0.289
0.049
0.065
0.088
0.088
0.088
0.088

𝑘37𝑏
𝑘38𝑏
𝑘39𝑏
𝑘40𝑏
𝑘41𝑏
𝑘42𝑏
𝑘𝑑𝑒𝑔𝑇2𝑅

s-1
s-1
s-1
s-1
s-1
s-1
min-1

0.046
0.04
0.012
0.012
0.035
0.035
0.0132

𝑘𝑑𝑒𝑔𝑇𝐺𝐹𝐵

min-1

𝑘𝑝𝑟𝑜𝑑𝑇2𝑅
𝑘𝑟

nM min
min

-1

0.347
-1

0.0190076
0.0333
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𝑘𝑝𝑟𝑜𝑑𝑇1𝑅

0.222
0.0571
0.49
0.65
0.88
0.88
0.88
0.88
0.18
0.22
0.22
0.01
0.01
0.014
0.014
0.61
0.54
0.018
0.013
0.26
0.26
0.00256

𝑘𝑖𝑚𝑝𝑆𝑚𝑎𝑑23

min-1

0.156

𝑘𝑒𝑥𝑝𝑆𝑚𝑎𝑑23

min-1

0.739

𝑘𝑖𝑚𝑝𝑆𝑚𝑎𝑑4
𝑘𝑖𝑚𝑝𝐶𝑜𝑚𝑝𝑙𝑒𝑥

min-1
min-1

0.156
0.889

𝑘𝑒𝑥𝑝𝑆𝑚𝑎𝑑4

min-1

0.355

𝑘𝑜𝑓𝑓𝑆𝑚𝑎𝑑𝑠

min-1

1

𝑘𝑑𝑒𝑝ℎ𝑜𝑆𝑚𝑎𝑑𝑠

min-1

0.394

𝑘𝑜𝑓𝑓𝑛𝑠

min-1

2.073285

𝑘𝑎𝐿𝑅𝐶
𝑘𝑑𝑖𝑠𝑠𝐿𝑅𝐶
𝑘𝑙𝑖𝑑
𝑘𝑝ℎ𝑜𝑆𝑚𝑎𝑑23
𝑘𝑜𝑛𝑆𝑚𝑎𝑑𝑠
𝑘𝑜𝑛𝑛𝑠

-1

nM min
min-1
(nMmin)-1
(nMmin)-1
(nMmin)-1
min-1
-1

min
(nMmin)-1
min-1
(nMmin)-1
(nMmin)-1
(nMmin)-1
min-1
min-1
(nMmin)-1
(nMmin)-1
(nMmin)-1
(nMmin)-1
nM min-1
nM
nM

117.897
0.0438111
0.0233678
0.0488268
0.198472
0.0505413
0.182
0.05
0.133
0.0909
1
1
206
0.417
0.423
0.0000822
1
1
150
9
8

-1

𝑘44
𝑘46

min
min-1

0.0182
0.267

𝑘48𝑏
𝑘49𝑏
𝑘50𝑏
𝑘52

min-1
min-1
min-1
min-1

0.909
50
120
206

min-1
min-1
min-1
min-1
nM
nM min-1
min-1

0.000257
0.167
30
1200
10
15
1.5

𝑘54
𝑘56
𝑘57𝑏
𝑘58𝑏
𝐾𝑚1
𝑉𝑚𝑎𝑥2
𝑘𝑐𝑎𝑡1
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𝑘43
𝑘45
𝑘47
𝑘48
𝑘49
𝑘50
𝑘51
𝑘53
𝑣12
𝑘55
𝑘57
𝑘58
𝑉𝑚𝑎𝑥1
𝐾𝑖
𝐾𝑚2

-2

𝐾𝑚3
𝐾𝑚4
𝐾𝑚5
𝐾𝑚6
𝐾𝑚7
𝐾𝑚8
𝐾𝑚9
𝑘60
𝐾𝑚10
𝐾𝑚11
𝑘61
𝐾𝑚12
𝐾𝑚13
𝐾𝑚14

nM
nM
nM
nM
nM
nM
nM
min-1
nM
nM
min-1
nM
nM
nM

15
15
15
15
15
15
9
39
12
15
0.015
15
15
15

𝑉𝑚𝑎𝑥3
𝑘𝑐𝑎𝑡2
𝑉𝑚𝑎𝑥4
𝑘𝑐𝑎𝑡3
𝑉𝑚𝑎𝑥5
𝑘𝑐𝑎𝑡4
𝑘59
𝑉𝑚𝑎𝑥6
𝑘𝑐𝑎𝑡5
𝑛
𝑘𝑐𝑎𝑡6
𝑘𝑐𝑎𝑡7
𝑉𝑚𝑎𝑥7
𝑘62

nM min-1
min-1
nM min-1
min-1
nM min-1
min-1
(nMmin)-1
nM min-1
min-1
min-1
min-1
nM min-1
min-1

45
1.5
45
1.5
45
1.5
0.15
45
0.6
2
1.5
1.5
45
0.000001
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APPENDIX E: RATE EQUATIONS
Species
Initial
Conc.
FAKo
0
FAKop
0

Src
Srcp
SrcpFAKop
SrcpFAKopp
SrcpFAKoppp

90nM
0
0
0
0

Shc
FAKopSh

1000nM
0

FAKopShP

0

ShP

0

Rate Equation
k1*(1-v*w/dG)^(1/v-1)*exp(dG*(1-v*w/dG)^(1/v))
(k2cat*FAKop^2)/(k2m+FAKop)-(k4*FAKop*Srcpk4b*SrcpFAKop)-(k7*FAKop*Shck7b*FAKopSh)+(k9*FAKopShPk9b*FAKop*ShP)+(k21*FAKopShPGS-k21b*ShPGS*FAKop)
-((k3cat*Src^2)/(k3m+Src))
((k3cat*Src^2)/(k3m+Src))
k4*FAKop*Srcp-k4b*SrcpFAKop-k5cat*SrcpFAKop
k5cat*SrcpFAKop- k6cat*SrcpFAKopp
k6cat*SrcpFAKopp-(k10*SrcpFAKop*Grb2k10b*SrcpFAKopppG)-(k18*SrcpFAKoppp*GSk18b*SrcpFAKopppGS)
-(k7*FAKop*Shc-k7b*FAKopSh)+V12max*ShP/(k12m+ShP)
k7*FAKop*Shc-k7b*FAKopSh-(k8*FAKopShk8b*FAKopShP)
k8* FAKopSh-k8b*FAKopShP-(k9*FAKopShPk9b*FAKop*ShP)-(k13*FAKopShP*Grb2k13b*FAKopShPG)-(k20*FAKopShP*GSk20b*FAKopShPGS)
k9*FAKopShP-k9b*FAKop*ShP-(k11*ShP*Grb2k11b*ShPG)-(V12max*ShP/(k12m+ShP))-(k17*ShP*GSk17b*ShPGS)
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Grb2

48nM

SrcpFAKopppG

0

ShPG
FAKopShPG

0
0

SOS

62nM

GS

0

ShPGS

0

SrcpFAKopppGS

0

FAKopShPGS

0

RasGTP

0

RasGDP

120nM
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-(k10*SrcpFAKop*Grb2-k10b*SrcpFAKopppG)(k11*ShP*Grb2-k11b*ShPG)-(k13*FAKopShP*Grb2k13b*FAKopShPG)-(k14*Grb2*SOS-k14b*GS)
k10*SrcpFAKop*Grb2-k10b*SrcpFAKopppG(k16*SrcpFAKopppG*SOS-k16b*SrcpFAKopppGS)
k11*ShP*Grb2-k11b*ShPG-(k15*ShPG*SOS-k15b*ShPGS)
k13*FAKopShP*Grb2-k13b*FAKopShPG(k19*FAKopShPG*SOS-k19b*FAKopShPGS)
-(k14*Grb2*SOS-k14b*GS)-(k15*ShPG*SOS-k15b*ShPGS)-(
k16*SrcpFAKopppG*SOS-k16b*SrcpFAKopppGS) (k19*FAKopShPG*SOS-k19b*FAKopShPGS)
k14*Grb2*SOS-k14b*GS-(k17*ShP*GS-k17b*ShPGS)(k18*SrcpFAKoppp*GS-k18b*SrcpFAKopppGS)(k20*FAKopShP*GS-k20b*FAKopShPGS)
k15*ShPG*SOS-k15b*ShPGS+ k17*ShP*GSk17b*ShPGS+k21*FAKopShPGS-k21b*ShPGS*FAKop
k16*SrcpFAKopppG*SOS-k16b*SrcpFAKopppGS-(
k18*SrcpFAKoppp*GS-k18b*SrcpFAKopppGS)
k19*FAKopShPG*SOS-k19b*FAKopShPGS+
k20*FAKopShP*GS-k20b*FAKopShPGS-(k21*FAKopShPGSk21b*ShPGS*FAKop)
k22*RasGDP*RGS/(k22m+RasGDP)(V23max*RasGTP/(k23m+RasGTP))(k24*Raf*RasGTP-k24b*RasRaf)
V23max*RasGTP/(k23m+RasGTP)-(
k22*RasGDP*RGS/(k22m+RasGDP))

Raf
RasRaf

0.013uM
0

RasRafMEK
MEKERK
pMEKERK

0
0
0

MEKERKn

0

pMEKERKn

0

pMEK
pERK
pMEKn
ERKn

0
0
0
0

pERKn
MEK

0
1.39uM

MEKn

0

ERK

0.96uM

exTGFB

0
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-(k24*RasRaf-k24b*RasGTP*Raf)
k24*Raf*RasGTP-k24b*RasRaf-(k25*RasRaf*MEKk25b*RasRafMEK)+k30*RasRafMEK
k25*RasRaf*MEK-k25b*RasRafMEK-k30*RasRafMEK
k26*MEK*ERK-k26b*MEKERK
k27*pMEK*ERK-k27b*pMEKERK-k31*pMEKERK(k42*pMEKERKn-42b*pMEKERK)
k28*MEKn*ERKn-k28b*MEKERKn-(k41*MEKERKnk41b*MEKERK)
k29*pMEKn*ERKn-k29b*pMEKERKn-32*pMEKn*ERKn(k42*pMEKERKn-k42b*pMEKERK)
k30*RasRafMEK+k31*pMEKERK+k38*pMEKn-k38b*pMEK
k31*pMEKERK+k40*pERKn-40b*pERK
k32*pMEKERKn-(k38*pMEKn-k38bpMEK)
k32*pMEKERKn+k36*pERKn-(k39*ERKn-k39b*ERK)(k28*MEKn*ERKn-k28b*MEKERKn)-(k29*pMEKn*ERKnk29b*pMEKERKn)
-(k40*pERK-k40b*pERKn)
k33*pMEK+k37*MEKn-k37b*MEK-(k25*RasRaf*MEKk25b*RasRafMEK)
k34*pMEKn-k28*MEKn*ERKn-k28b*MEKERKn(k37*MEKn-k37b*MEK)
k35*pERK-(k26*MEK*ERK-k26b*MEKERK)(k27*pMEK*ERK-k27b*pMEKERK)+(k39*ERKn-k39b*ERK)
-(Vc/Vmed)*kaLRC*exTGFB*T2Rsurf*T1Rsurfkonns*exTGFB+koffns*TGFBns

T1Rsurf

LRCsurf

0.702494n
M
6.52344n
M
0.201077n
M
1.43997n
M
0

LRCendo
Smad23c

0
60.6nM

Smad23n

28.5nM

Smad4c

50.8nM

Smad4n

50.8nM

PSmad23c

0

T1Rendo
T2Rsurf
T2Rendo
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kprodT1R-ki*T1Rsurf+kr*T1RendokaLRC*exTGFB*T2Rsurf*T1Rsurf
ki*T1Rsurf-kr*T1RendokdegT1R*T1Rendo+kdissLRC*LRCendo
kprodT2R-ki*T2Rsurf+kr*T2RendokaLRC*exTGFB*T2Rsurf*T1Rsurf
ki*T2Rsurf-kr*T2RendokdegT2R*T2Rendo+kdissLRC*LRCendo
kaLRC*exTGFB*T2Rsurf*T1Rsurf-ki*LRCsurfklid*LRCsurf*TSmad23pn
ki*LRCsurf-kdissLRC*LRCendo-kdegLRC*LRCendo
(Vn/Vc)*kexpSmad23*Smad23nkphoSmad23*Smad23c*LRCendo-kimpSmad23*Smad23c
(Vc/Vn)*kimpSmad23*Smad23ckexpSmad23*Smad23n+kdephoSmad23*PSmad23n
(Vn/Vc)*kexpSmad4*Smad4nkonSmads*PSmad23c*Smad4c+koffSmads*PSmad23Smad4ckimpSmad4*Smad4c
(Vc/Vn)*kimpSmad4*Smad4ckexpSmad4*Smad4n+koffSmads*PSmad23Smad4ckonSmads*PSmad23c*Smad4n
kphoSmad23*Smad23c*LRCendo-kimpSmad23*PSmad23c
+(Vn/Vc)*kexpSmad23*PSmad23nkonSmads*PSmad23c*Smad4c+koffSmads*PSmad23Smad4c2*konSmads*PSmad23c*PSmad23c
+2*koffSmads*PSmad23c*PSmad23c

PSmad23PSmad23c

PSmad23Smad4c
PSmad23n

PSmad23PSmad23n
PSmad23Smad4n
TGFBendo
TGFBns
Dshi
Dsha
APCpAxinpGSK3B

APCAxinGSK3B

0

konSmads*PSmad23c*PSmad23ckoffSmads*PSmad23PSmad23ckimpSmads*PSmad23PSmad23c
0
konSmads*PSmad23c*Smad4c-koffSmads*PSmad23PSmad4ckimpSmads*PSmad23PSmad4c
0
(Vc/Vn)*kimpSmad23*PSmad23ckexpSmad23*PSmad23n+koffSmads*PSmad23Smad4nkonSmads*PSmad23n*Smad4nkdephoSmad23*PSmad23n+2*(koffSmads*PSmad23PSmad23n
-konSmads*PSmad23PSmad23n)^2
0
(Vc/Vn)*kimpSmads*PSmad23PSmad23ckoffSmads*PSmad23PSmad23n+konSmads*PSmad23n^2
0
(Vc/Vn)*kimpSmads*PSmad23PSmad4ckoffSmads*PSmad23PSmad4n+konSmads*PSmad23n*Smad4n
0
kdissLRC*LRCendo-kdegTGFB*TGFBendo
0
konns*exTGFB-koffns*TGFBns
100nM
-k43*Dshi+ k44*Dsha
0
k43*Dshi+-k44*Dsha
0.0153nM k46*APCAxinGSK3B- k47*APCpAxinpGSK3B-(
k50*APCpAxinpGSK3B*Bcatenink50b*BcateninAPCpAxinpGSK3B)+
k52*BcateninpAPCpAxinpGSK3B
0.0076 nM -k45*Dsha*APCAxinGSK3B- k46*APCAxinGSK3B+
k47*APCpAxinpGSK3B+ k48*GSK3B*APCAxink48b*APCAxinGSK3B
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GSK3B

49.1372
nM

APCAxin

0.0015 nM

APC

96.6019
nM
0.002 nM

BcateninAPCpAxinpGS
K3B
BcateninpAPCpAxinpGS
K3B
pBcatenin
Bcatenin

0.002 nM

Axin

0.0008 nM

TCF
BcateninTCF
BcateninAPC
Raf1

6.1879 nM
8.8121 nM
3.4392 nM
112.5585
nM

0.9881 nM
42.7224
nM
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k45*Dsha*APCAxinGSK3B-(k48*GSK3B*APCAxink48b*APCAxinGSK3B)(kcat7*pERK*GSK3B/(Km13+GSK3B))+Vmax7*GSK3Bp/(K
m14+GSK3Bp)
k45*Dsha*APCAxinGSK3B-(k48*GSK3B*APCAxink48b*APCAxinGSK3B)+k49*APC*Axin-k49b*APCAxin
-(k49*APC*Axin-k49b*APCAxin)-(k58*APC*Bcatenink58b*BcateninAPC)
k50*APCpAxinpGSK3B*Bcatenink50b*BcateninAPCpAxinpGSK3Bk51*BcateninAPCpAxinpGSK3B
k51*BcateninAPCpAxinpGSK3Bk52*BcateninpAPCpAxinpGSK3B
k52*BcateninpAPCpAxinpGSK3B-k53*pBcatenin
-(k50*APCpAxinpGSK3B*Bcatenink50b*BcateninAPCpAxinpGSK3B)+
v12-k54*Bcatenin-(k57*Bcatenin*TCF-k57b*BcateninTCF)(k58*APC*Bcatenin-k58b*BcateninAPC)
-(k49*APC*Axink49b*APCAxin)+k55+k62*(Bcatenin+BcateninTCF)-k56*Axin
-(k57*Bcatenin*TCF-k57b*BcateninTCF)
k57*Bcatenin*TCF-k57b*BcateninTCF
k58*APC*Bcatenin-k58b*BcateninAPC
-kcat1*RasGTP*Raf1/(Km3+Raf1)+Vmax3*Raf/(Km4+Raf)
+kcat4*pERK*Raf1RKIP/(Km9+Raf1RKIP)-(k59*Raf1*RKIPk60*Raf1RKIP)-kcat6*XX*Raf1/(Km12+Raf1)

Raf1RKIP
RKIP
RKIPp
XX
GSK3Bp

180.9595
nM
418.1788
nM
0.8619 nM

-kcat4*pERK*Raf1RKIP/(Km9+Raf1RKIP)
+k59*Raf1*RKIP-k60*Raf1RKIP
-(k59*Raf1*RKIPk60*Raf1RKIP)+Vmax6*RKIPp/(Km10+RKIPp)
-Vmax6*RKIPp/(Km10+RKIPp)
+kcat4*pERK*Raf1RKIP/(Km9+Raf1RKIP)
10.263 nM kcat5*BcateninTCF^n/(Km11^n+BcateninTCF^n)-k61*XXkcat6*XX*RasRaf/(Km12+RasRaf)
0.85544
kcat7*pERK*GSK3B/(Km13+GSK3B)nM
Vmax7*GSK3Bp/(Km14+GSK3Bp)
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